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Endoplasmic Reticulum stress (ER) and oxidative stress are two related processes which 
can cause the death of macrophages within the artery wall. Atherosclerosis is a chronic 
inflammatory disease caused by the abnormal deposition of cholesterol ester filled 
macrophages within the inner arterial wall so limiting flow of oxygenated blood to 
various organs of the body. Scavenger receptors such as CD36 are responsible for the 
absorption of heavily oxidized low density lipoprotein (oxLDL) forming atherosclerotic 
plaque in the artery wall. The macrophage antioxidant 7, 8-dihydroneopterin 
downregulate macrophage CD36 so preventing cholesterol esters accumulations in the 
cells. The ER-stress triggered by free unesterified cholesterol accumulation causes 
perturbations in ER function resulting in incorrectly folded proteins. ER stress causes 
activation of three ER proteins resulting in signaling pathways that lower ER stress as a 
part of Unfolded Protein Response (UPR). However, unresolved ER-stress leads to the 
activation of the CHOP (C/EBP-homologous protein) protease which causes 
mitochondrial-mediated cell death. The research investigated the effect of oxLDL causing 
CHOP activation in U937 cell line and its inhibition by 7, 8-dihydroneopterin. 
Thapsigargin (TG), an ER calcium agonist, was found to be a suitable positive control of 
ER stress-mediated cell death in U937 cells. TG was very cytotoxic causing a 70% loss on 
cell viability when treated with at only 100 nM. The mitochondrial membrane potential 
surprisingly increased with TG treatment but at the same time there was a large loss of 
intact cells which may have masked the loss of mitochondrial potential. 
Western blot analysis showed 50 nM TG caused maximum expression of ER-stress 
marker CHOP in U937 cells. The expression increased with increasing concentrations of 
TG suggesting the potential of TG in triggering CHOP activation through the unresolved 
ER-stress-UPR pathway. Cu-oxLDL caused CHOP expression in U937 cells with increasing 




The addition of the macrophage generated antioxidant 7, 8-dihydroneopterin reduced 
the CHOP expression in U937 cells. Treatment with 200 µM 7, 8-dihydroneopterin 
reduced the levels of CHOP to 57.67% of control.  
ACAT inhibitor (Sandoz 580-35) was expected to trigger ER-stress through the buildup 
of free cholesterol. Instead the inhibitor caused an increase in cell survival when the U937 
cells treated with a sub-lethal dose of oxLDL. The inhibitor prevented cell death at lower 
concentrations of 10 µg/mL. However, it was observed that the ACAT inhibitor is lethal 
to cells when given at 25 µg/mL and above concentrations in the absence of oxLDL. 
The results confirm that TG and oxLDL induced cell death in U937 cells through ER-stress 
pathway by CHOP activation. The results showed the potential of macrophage antioxidant 
7, 8-dihydroneopterin in downregulating CHOP expression suggesting the suppression of 
CHOP-induced ER-stress in the cells. The research also demonstrated that ACAT inhibitor 
at lower concentrations can increase the cell survival rates during oxLDL induced cell 
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1  INTRODUCTION 
 
1.1  Atherosclerosis 
Atherosclerosis is a chronic inflammatory disease caused by the accumulation of 
cholesterol-esters filled macrophages (atherosclerotic plaque) in the inner arterial wall 
which limits the flow of oxygenated blood to various organs of the body (Ross, 1999; 
Shoenfeld, Sherer, & Harats, 2001). The disease pathologically happens to start when the 
monocytes start migrating into the arterial lumen and differentiate into macrophages 
(Libby, Ridker, & Maseri, 2002). These macrophages start taking up the oxidized form of 
low density lipoproteins (oxLDL) through cell surface receptors (called scavenger 
receptors) (Moore & Freeman, 2006) leading to the formation of foam cells which drive 
events in the development of atherosclerosis. The interaction of these scavenger 
receptors and oxLDL also triggers an immune response which induces cytokine secretion, 
recruiting immune cells infiltrating in the arterial lumen and provoking an inflammatory 
response (Jiang et al., 2012). The foam cells undergo physiological changes (discussed in 
1.1.1) with the progression of atherosclerosis as these scavenger receptors causes 
macrophages to starts accumulating oxLDL in larger amounts resulting in the hardening 
of plaque through calcification over time, obstructing the arteries and diminishing the 
flow of oxygenated blood to various organs of the body (Anderson, 1999) (Libby, 2006; 
Libby et al., 2002). Hardened plaque not only contains calcium phosphate but also 
contains lipids, cholesterol, and fatty acids (Libby et al., 2002) (Anderson, 1999) and its 
position in the arteries distinguishes it in different types (Dobmeyer, Lohrmann, & 
Feussner, 1996; Stary et al., 1995). Plaque formation characterizes coronary artery 
disease in the coronary artery which results in angina or chest pain (Hansson, 2005). 
Carotid artery disease is marked by the build-up of plaque in the carotid artery which can 
lead to a stroke when ruptured (Sobieszczyk & Beckman, 2006). The peripheral arterial 
disease is a result of plaque accumulation in arteries supplying blood to legs, arms, pelvis, 
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etc. (Ouriel, 2001) and chronic kidney disease is caused by plaque development in renal 
arteries (Schiffrin, Lipman, & Mann, 2007).  
1.1.1 Pathogenesis of atherosclerosis  
A normal arterial wall is surrounded by the three distinct concentric layers bounded by 
the arterial lumen. The intima consists of smooth muscle cells (SMCs) and endothelial 
cells is adjoined by the arterial lumen. The middle layer media is composed of mainly 
SMCs that are organized in layers depending upon the arterial size. Lastly, the arterial 
adventitia, the outermost layer typically consists loose matrix of elastin, SMCs, 
fibroblasts, and collagen. 
 
Figure 1: Stages in atherosclerotic plaque formation. 
Lesion-prone arterial sites are marked by the intimal thickening which is considered 








different stages depending upon development, and progression of the lesion. The 
occurrence of lipid-loaded foam cells in the intima of the artery is the peculiarity of 
atherosclerosis and is referred as type II lesions (Figure 1A). Foam cell formation occurs 
when the scavenger receptors present on the surface of macrophages gathers modified 
form of low density lipoproteins (LDL) known as oxLDL (Discussed in 1.1.2) and migrated 
into the intima. Occurrence of foam cells from the macrophages in the lesson marks the 
initial event in atherosclerosis (Boullier et al., 2001). As the formation of foam cells 
continues; the macrophages start developing necrotic core producing type III lesions or 
preatheroma (Figure 1B) which consist of small pools of lipid. With the progression of 
the lesion, type III lesion advances to type IV lesion or atheroma (Figure 1C) by separating 
thin tissue of lipid core from the arterial lumen whereas, Type V lesions or fibroatheroma 
(Figure 1D) are characterized by the occurrence of fibrous cap thickening. Type VI lesions 
(Figure 1E) are the matured lesions that often exhibit the framework which is more 
complicated and is distinguished by the development of calcified fibrous areas.  
There have been countless efforts to demystify the complex events related to 
atherosclerosis advancement which has resulted in the development of three distinct 
hypotheses; 1) The response–to–injury, 2) The response–to–retention and 3) oxidative 
modification. These hypotheses are not irreconcilable but are preferably different 
notions that are essential and adequate to uphold the atherosclerotic lesions 
enhancement. The response–to–injury hypothesis proposes a primordial step in 
atherogenesis is endothelial denudation that results in various compensatory counter-
responses that modify the normal vascular homeostatic properties (Ross, 1993). William 
and Tabas suggested Response-to-retention theory in 1995 (Williams & Tabas, 1995) 
which proposed that plaque development is activated as a result of diffusion and 
retention of lipoprotein molecules present within the sub-endothelial layer of the intima, 
binding to proteoglycan chains with high affinity. Long carbohydrate chains of 
glycosaminoglycans (GAGs) covalently attached to core protein via glycosidic linkages 
are the classic feature of proteoglycans. The theory lies upon the concept of repeating 
disaccharide units of GAGs containing negatively charged sulphate or carbohydrate 
groups attracted to the positively charged lysine groups of ApoB100 resulting in 
adherance to GAG matrix as the LDL moves through the sub-endothelial space (Evanko, 
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Raines, Ross, Gold, & Wight, 1998; Libby, Ridker, & Hansson, 2009). Rentention and 
accumulation of LDL in the intima further causes its oxidative modification by oxidants 
resulting in its uptake by macrophages via scavenger receptors resulting in foam cell 
formation. However, oxidative modification hypothesis emphasizes more on the concept 
that LDL is atherogenic when is taken by the macrophages in the modified form rather 
than native form by so-called “Scavenger Receptor” pathway (Napoli et al., 1997; 
Rosenfeld, 1996). During this process the LDL is oxidized to oxLDL and is readily taken 
up by the scavenger receptors (Discussed in 1.1.2), converting them into cholesterol-
loaden foam cells which further carry the process of atherogenesis.  
1.1.2 Oxidative low-density lipoproteins as a contributor to 
cell death 
OxLDL is believed to be a major contributor to the death of macrophage cell within the 
plaque through a combination of factors which include the presence of cytotoxic levels of 
oxLDL (Moore & Freeman, 2006). OxLDL binding occurs through several receptors 
present on the surface of macrophages which include Scavenger Receptor–A1, A2 (SR-A1, 
A2), cluster of differentiation 36 (CD36), scavenger receptor–B (SR-B) and lectin-like 
oxidized low-density lipoprotein-1 (LOX-1) (Levitan, Volkov, & Subbaiah, 2010) (Figure 
2). Among the receptors aforementioned, LOX-1 is a major oxLDL receptor that has been 
identified in endothelial cells (ECs) (Sawamura et al., 1997) whereas SR-A and CD36 are 
the main scavenger receptors identified in macrophages that play a critical role in foam 
cell formation and development of atherosclerotic lesion (Boullier et al., 2001; Collot-
Teixeira, Martin, McDermott-Roe, Poston, & McGregor, 2007; Huh, Pearce, Yesner, 
Schindler, & Silverstein, 1996; Park, 2014).  
Since cholesterol levels do not regulate uptake of oxLDL by CD36, therefore the oxLDL 
taken up by the macrophages gathers a more significant quantity of cholesterol 
converting them into “foam cells” which in later stages results in plaque formation 
(Goldstein, Ho, Basu, & Brown, 1979). The appearance of foam cells originating from 
macrophages or SMCs in atherosclerotic lesions represents the initial event in 
atherogenesis (Ira Tabas, Williams, & Borén, 2007) (Figure 1). (T. Chang, Chang, & Cheng, 
1997). Uptake of oxLDL by the macrophages causes excess cholesterol accumulation 
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(Moore & Tabas, 2011). This excess cholesterol present in the foam cells undergoes efflux 
on HDL by ATP binding cassette A1 and G1 (ABCA1 And G1) transporters and is then 
transported to the liver for further excretion. This process is known as reverse 
cholesterol transport. 7-ketocholesterol (7-KC), being a major oxysterol in oxLDL, is also 
known to impair ABCA1 transporter, as a result FC is prevented from moving out of the 
cell. This causes membrane vesicles which are filled with CE to accumulate in the 
cytoplasm (Brown & Jessup, 1999).  
 
Figure 2: Role of oxLDL in foam cell formation taken from (Kathryn J. Moore, and, 
& Fisher, 2013) 
 
1.1.3 Role of scavenger receptors in foam cell formation and 
atherosclerosis. 
OxLDL uptake and atherosclerosis progression are mainly driven by CD36 and SR-A 
therefore; these receptors have been of interest for atherosclerotic studies. OxLDL 
products such as phospholipids and oxysterols are being generated when oxLDL is 
internalized by CD36 by the action of lipoxygenase (LPO) (Febbraio, Hajjar, & Silverstein, 
2001; Rahaman et al., 2006; Steinberg, 2002). These oxidized lipids generated within the 
oxLDL also serves as a ligand for nuclear hormone receptor peroxisome proliferator 
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activated receptor-γ (PPAR-γ), upregulating the expression of CD36 which further 
facilitates the uptake of oxLDL (Nagy, Tontonoz, Alvarez, Chen, & Evans, 1998; Tontonoz, 
Nagy, Alvarez, Thomazy, & Evans, 1998). This increases expression of CD36 receptors on 
the surface of macrophages causes higher uptake of oxLDL and atherosclerotic foam cell 
formation (Febbraio et al., 2001; Rahaman et al., 2006). A study performed on Apoe-/- 
mice lacking CD36 demonstrated a reduction in atherosclerotic lesion area by 76% 
indicating the importance of CD36 mediated oxLDL uptake by macrophages is necessary 
for foam cell formation and atherosclerotic lesion development (Febbraio et al., 2000). 
SR-B1 share high homology and ligand repertoire to that of CD36 (S. Acton et al., 1996; S. 
L. Acton, Scherer, Lodish, & Krieger, 1994; Webb, De Villiers, Connell, de Beer, & van der 
Westhuyzen, 1997), however, both the receptors differ in functions of lipid metabolism. 
CD36 binds oxLDL in large amount leading to macrophage foam cell formation whereas 
SR-B1, which is mainly present on the liver, play a crucial role in binding high-density 
lipoproteins (HDL) and reverse cholesterol transport by facilitating cholesterol from and 
transferring it back to HDL (S. Acton et al., 1996). SR-B1 is expressed in liver, 
macrophages and steroidogenic tissues such as ovaries, adrenal gland and testis (S. Acton 
et al., 1996). However, in macrophages SR-B1 mediates the re-uptake of cholesterol 
esters by inhibiting ATP-binding cassette 1 (ABCA1) facilitated cholesterol efflux (Chen, 
Silver, Smith, & Tall, 2000; Van Eck, Pennings, Hoekstra, Out, & Van Berkel, 2005) 
indicating the protective role played by SR-B1 in arterial wall (A. C. Li & Glass, 2002). 
LOX-1 has been identified as the first major oxLDL receptor in endothelial cells 
(Sawamura et al., 1997) and is expressed on macrophages and smooth muscle cells 
(SMCs) (Draude, Hrboticky, & Lorenz, 1999). LOX-1 is not only expressed in ECs in early 
stages of atherogenesis but is highly expressed in intimal SMCs and macrophages in 
carotid atherosclerotic plaque (Kataoka et al., 1999), suggesting the involvement of LOX-
1 in endothelial activation and formation of foam cells. LOX-1 is also known to bind mildly 
oxidized LDL, highly oxidized LDL (such as Cu-oxLDL) and delipidated oxLDL suggesting 
its capability of binding and recognizing modified forms of oxidized lipoproteins (Levitan 
et al., 2010). LOX-1 binds oxLDL by activating NADPH oxidase (NOX) leading to the rapid 
elevation in intracellular ROS such as superoxides, hydrogen peroxide (H2O2), and 
hypochlorite (HOCl). NOX is an important producer of ROS in the macrophages and is 
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believed to be a principle superoxide-generating enzyme, which is highly essential in 
redox signalling (Dworakowski, Anilkumar, Zhang, & Shah, 2006). In later stages of 
atherosclerosis, these ROS reacts with intracellular nitrous oxide (NO) which causes a 
decrease in NO levels and upregulation of LOX-1; culminating the excess production of 
ROS (Ou et al., 2010). According to the pathway proposed by (Hong et al., 2014), 
upregulation of LOX-1 by oxLDL and intracellular NOX levels triggers three ER–stress 
(Endoplasmic Reticulum–Stress) pathways which further leads to activation of 
proapoptotic mediators such as CHOP, Bcl-2, and caspase-12 eventually leading to 
apoptosis in endothelial cells. We hypothesize that oxLDL induction alone is sufficient to 
induce ER-stress marker CHOP and initiate ER-stress mediated cell death in 
macrophages. 
1.2  Endoplasmic reticulum (ER) and atherosclerosis. 
The endoplasmic reticulum is a complex eukaryotic organelle consisting of extended 
membrane network with supplied machinery for protein folding and maturation. The ER 
lumen contains higher calcium concentration and dedicated enzymes for protein 
glycosylation. It facilitates the maintenance and reducing on redox potential that 
promotes disulfide bond formation for secretory protein maturation. These conditions 
are essential for optimum function of ER–chaperones such as glucose-related protein 78 
(GRP78/BiP)  and enzymes such as protein disulphide isomerase (PDI), calnexin, 
calreticulin, and peptidylprolyl isomerase that are required for protein folding, their 
transportation, and post-translational modification (Ma & Hendershot, 2004; Tu & 
Weissman, 2004).  
1.2.1 ER-stress and atherosclerosis. 
ER function affects the course of atherosclerosis in several ways. The first way involves 
the disturbances in the homeostatic processes of ER leading to the unfolding of proteins 
entering ER and forcing the organelle to undergo ER-stress. Upon the induction of ER-
stress, the organelle responds by triggering specific measures that ensure the proper 
folding of proteins by the process known as unfolded protein response (UPR) (See 1.2.2) 
which is governed by three principal ER-membrane proteins viz. inositol-requiring 
enzyme 1 α (IRE1α) (see 1.2.2.1), protein kinase-like ER kinase (PERK) (See 1.2.2.2) and 
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activating transcription factor-6 (ATF-6) (see 1.2.2.3). Altogether these proteins help in 
reduction of overall protein load and increase the folding capacity of ER, so resolving ER-
stress. However, the failure of these transmembrane proteins, due to increased protein 
load, leads to activation of downstream effectors and apoptotic signals causing cellular 
death (Discussed in 1.2.3). The second mechanism involves the failure of cholesterol 
esterase enzyme, acyl-coenzyme A: cholesterol acyltransferase (ACAT). ACAT is a 
primary enzyme that converts free cholesterol (FC) to cholesterol esters (CE). However, 
its failure leads to the accumulation of FC into the ER which usually is normally in low 
cholesterol, so the increasing cholesterol causes ER stress and potential cell death 
(discussed in 1.2.4). 
The disturbances in homeostasis processes such as calcium balance, oxidative stress and 
chronic inflammation result in the dysfunctioning of ER, which leads to the state in which 
the protein misfolds or delayed folding in ER by the mechanism known as ER-stress 
(Hotamisligil, 2010). These stimuli activate various signals that enhance the formation of 
new proteins to deal with stress and at the same time reducing the load of general protein 
synthesis (Hetz, Chevet, & Oakes, 2015; Ron & Walter, 2007). This mechanism of 
activating the series of responses to ensure the correct folding of proteins is termed as 
UPR (Unfolded Protein Response) (Ron & Walter, 2007). The second mechanism by 
which the UPR repairs the homeostasis is by the process termed as ER-associated 
degradation (ERAD) (Meusser, Hirsch, Jarosch, & Sommer, 2005; Travers et al., 2000). 
ERAD ensures translocation of the unfolded proteins from ER to the cytoplasm. In the 
cytoplasm, the degradation of these unfolded proteins takes place via ubiquitin-
proteasome system (UPS) (Meusser et al., 2005; Travers et al., 2000). Another mechanism 
by which ERAD carries protein degradation is stimulated is through autophagy (Meusser 
et al., 2005). 
1.2.2 Unfolded Protein Response (UPR) and Transmembrane 
proteins. 
When the endoplasmic reticulum experiences imbalance in the homeostasis processes 
such as oxidative stress, chronic inflammation and calcium balance, it leads to misfolding 
of proteins creating stress on endoplasmic reticulum (ER-stress). Corresponding to ER-
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stress, the ER membrane proteins triggers series of responses to ensure the correct 
protein folding thereby reducing the load of misfolded proteins on the endoplasmic 
reticulum. This mechanism of ensuring and repairing the correct protein folding is 
termed as unfolded protein response (UPR). The UPR is operated by three main ER 
resident proteins. i) Inositol-requiring enzyme 1 alpha, (IRE1 α) ii). Protein Kinase-like 
ER kinase (PERK) and iii) Activating Transcription Factor–6 (ATF-6). These proteins bind 
to chaperone GRP78/BiP that dwell in ER membrane monitoring the health of ER and 
ensuring the proteins are folded correctly (Shutong Yao, 2014). However, upon 
continuous induction of ER–stress, these transmembrane proteins, and their 
downstream effectors induce cell death at different levels. 
1.2.2.1 Inositol–Requiring Enzyme 1 α (IRE1α) 
IRE1α, an ER transmembrane protein consists of kinase and endoribonuclease domains 
(which carries kinase and RNase activities) on its cytosolic surface (Wang et al., 1998). 
RNA degradation is performed by RNase which reduces the synthesis of proteins by a 
process known as regulated IRE1–dependent mRNA decay (RIDD) (Hollien & Weissman, 
2006). However, RNase activity of IRE1α is sequence-specific under low–activation 
conditions. They are involved in the regulation of mRNA of specific genes, particularly 
XBP1 (X box–binding protein 1). Upon the activation of IRE1α, a small intron from XBP1 
mRNA gets removed to undergo frameshift which leads to the formation of spliced XBP1 
(XBP1s). This splicing is a marker of UPR activation (Cawley, Deegan, Samali, & Gupta, 
2011), but besides being a marker it also acts as an essential controller of UPR as it is 
responsible for activation of number of genes that are transcriptionally needed for 
reviving protein folding capacity of ER (Acosta-Alvear et al., 2007).  
1.2.2.2 Protein kinase–Like ER Kinase (PERK) 
PERK is another ER transmembrane protein which participates in UPR by regulating 
oxidative stress and lowering protein translation. PERK not only phosphorylates and 
activates transcription factor NRF2 (Nuclear factor (erythroid-derived 2)-like 2) which 
induces antioxidant proteins (Cullinan et al., 2003), but also helps in phosphorylation of 
initiation factor 2α(eIF2α) (Harding, Zhang, & Ron, 1999), blocking translation and 
initiating cell survival by reducing the accumulation of unfolded or misfolded proteins 
thereby relieving ER stress. However, if eIF2α is inhibited, ATF4 (Activating 
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Transcription factor 4) which is belongs to CCAAT/enhancer binding protein family 
(C/EBP), family of transcription factors; is induced, and activates certain genes which 
functions in protein synthesis and their secretion, amino acid metabolism and transport, 
and antioxidant stress stimuli (J. Han et al., 2013; Harding et al., 2003). ATF4 also plays a 
significant role in the induction of cell death through activation of CHOP/GADD153 
(C/EBP–homologous protein/Growth Arrest and DNA damage-inducible protein 153) 
(Discussed in 1.2.3).  
1.2.2.3 Activating Transcription Factor–6 (ATF–6) 
Activating Transcription Factor–6 (ATF–6) is a third transmembrane ER–protein, but it 
acts as a transcription factor when cleaved. Upon ER–stress, ATF–6 translocates to Golgi 
and gets cleaved by proteases Site protease 1 (SP1) and Site protease 2 (SP2) releasing 
the active form of ATF–6 into the cytosol (Shen, Chen, Hendershot, & Prywes, 2002; Ye et 
al., 2000). ATF–6 in its active form increases the transcription of XBP1 mRNA which 
targets IRE1α (Yoshida, Matsui, Yamamoto, Okada, & Mori, 2001).  
1.2.3 CHOP and CHOP-mediated apoptosis 
CHOP/GADD153 protein expressed by DNA Damage-inducible transcript 3 (DDIT3) gene 
was a first protein to be identified as a member of CCAAT/enhancer binding proteins 
(C/EBP) family. CHOP is expressed by ER-resident proteins (Figure 3) with binding sites 
for ATF–6, ATF–4, and XBPs enclosed within its promoters. These binding sites are highly 
essential to initiate ER–stress-induced apoptosis through different signalling pathways, 
which are both mitochondrial-dependent and independent.  
CHOP mediates cell death either by altering transcription of genes involved in apoptosis 
and oxidative stress or by replacing PERK mediated translation inhibition (Marciniak et 
al., 2004; Oyadomari & Mori, 2004). CHOP initiates apoptotic cell death through different 
signalling pathways. One mechanism links interaction of CHOP with the members of BCL–
2 family proteins which further involves BH3–only proteins (Figure 3). When BH3–only 
proteins are involved, they further activate BAX and BAK and initiates apoptosis through 
caspase–12 activation (Timmins et al., 2009).  
However, the other mechanism involves the fundamental function of NOX. NOX is a main 
ROS producer in the macrophages and is believed to be a dominant superoxide-
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generating enzyme which is highly essential in redox signalling (Dworakowski et al., 
2006). OxLDL triggers NOX activation in macrophages and vasculature enhancing the 
progression of atherosclerosis (Meyer & Schmitt, 2000; Pongnimitprasert, 2009). NOX 
facilitates the excess formation of (ROS), favouring oxidative stress and calcium signalling 
pathways through activation of CHOP–dependent ER–oxidase 1α (ERO1α) and initiating 
release of calcium through activation of ER calcium channel IP3R1 (Figure 3) (G. Li, Scull, 
Ozcan, & Tabas, 2010). Later, calcium in the cytoplasm triggers CaMKII (CaMKII is 
Serine/threonine-specific protein kinase regulated by Ca2+/Calmodulin complex and is 
essential for calcium homeostasis) which is the calcium-sensing enzyme (Figure 3). 
CaMKII further activates some downstream apoptotic pathways which include initiation 
of Fas death receptor and release of apoptogens from mitochondria (Scull & Tabas, 2011). 
Therefore, NOX plays a critical role in ER–stress-CHOP–IP3R activation–ER–Calcium 
release–CaMKII activation–NOX activation–oxidative stress, which is a bidirectional 
pathway. Reduction in peroxide accumulation and apoptosis in NOX2 -/- mice indicated 
that NOX is centrally involved in oxidative stress and apoptosis under ER–stress 
conditions (G. Li et al., 2010). NOX activation also causes membrane depolarization 
resulting in outer membrane permeabilization and releasing pro-apoptotic factors 
mainly cytochrome c causing mitochondrial-mediated apoptosis in ER-stressed 




Figure 3: ER-stress and unfolded protein response malfunction induced apoptosis 
taken from (Stacchiotti, Favero, & Rezzani, 2013). 
 
1.2.4 ACAT dysfunction and ER-stress. 
The microsomal enzyme acyl -coenzyme A: cholesterol acyltransferase (ACAT) regulates 
cholesterol homeostasis by modulating increasing levels of cholesterol by an esterifying 
excess of free cholesterol (FC) into cholesterol esters (CE). This enzyme is known to occur 
in two isoforms, ACAT-1 and ACAT-2. ACAT-1 is expressed only in macrophages and 
SMCs,  whereas ACAT1 and ACAT2 is expressed in the liver as well as intestine (Buhman, 
Accad, & Farese, 2000). With the progression of the atherosclerotic lesion, FC starts 
accumulating in macrophages and SMCs, as a result of ACAT, ABCA1 and ABCG1 
transporter malfunction (Moore & Tabas, 2011). The intracellular accumulation of excess 
FC causes macrophage death via endoplasmic reticulum-mediated cell apoptosis (Bo 
Feng et al., 2003; I Tabas, 2004). As the ER is the site of low cholesterol content, the 
accumulation of excess FC in the ER can cause membrane dysfunction and ultimately the 
ER stress causing dysfunctioning in unfolded protein response (UPR) pathways. 
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Dysfunction in unfolded protein response pathways further initiates apoptosis in 
macrophages proliferated by fas and CHOP-mediated apoptosis (I Tabas, 2004). In some 
animal models, it has been observed that the ACAT inhibitors effective in reducing the 
atheroma formation (Bocan et al., 1993). Inhibitors of ACAT-1 are capable of blocking 
esterification of cholesterol, prevent the transformation of macrophages into cholesterol 
loaded foam cells and slowing the progression of atherosclerosis (Bocan et al., 2000; 
Bocan et al., 1993; Kusunoki et al., 2001). However, we postulate that ACAT inhibitor 
(Sandoz 580-35) along with oxLDL would block the FC conversion to CE and mediate FC 
into the ER to initiate UPR which would further trigger apoptosis in U937 and human 
monocytes. 
1.3 Types of Cell Death 
1.3.1 Apoptosis 
Apoptosis is programmed cell death that takes place in multicellular organisms and is 
dependent on BCL-2 family proteins including pro-apoptotic and anti-apoptotic proteins 
which regulate the correlation between the ER and mitochondria. Cell shrinkage, nuclear 
fragmentation, chromatin condensation and membrane blebbing are some 
morphological characteristics of apoptotic cell death due to the proteolytic activity of 
caspase proteases (Kerr, Wyllie, & Currie, 1972; Taylor, Cullen, & Martin, 2008).  
Apoptosis proceeds via the intrinsic and extrinsic pathway. The intrinsic pathway 
initiates with mitochondrial outer membrane permeabilization (MOMP) which causes 
mitochondria to release cytochrome c (Scorrano et al., 2003; Scull & Tabas, 2011). 
Cytochrome c later binds to Apaf–1 and undergo a conformational change to form a 
complex known as apoptosome which activates initiator caspase, caspase-9. The initiator 
caspase further activates executioner caspases, caspase-3 and caspase-7 causing 
apoptotic cell death. However, in the extrinsic pathway (also known as death receptor 
(DR) Pathway), ligation of cell surface death receptors causes the recruitment of adaptor 
molecules like FAS-associated death domain protein (FADD) which binds and activates 
initiator caspase–8, which further cleaves and activates executioner caspases–7 and–9, 
and initiates apoptosis without mitochondrial outer membrane permeabilization 
(MOMP). Crosstalk between intrinsic and extrinsic pathway also occurs through caspase–
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8. Caspase–8 cleaves and activates BID (BCL-2 homology 3 (BH3) interacting domain) 
and MOMP, which further results in activating executioner caspases-3 and -7 further 
resulting in apoptosis (Tait & Green, 2010). 
1.3.2 Necrosis 
Necrosis, also referred to as accidental cell death, is portrayed by the loss of ion 
homeostasis which results in internal organelle structure degradation, cell swelling, 
disruption of nuclear membrane and rupture of the plasma membrane (Syntichaki & 
Tavernarakis, 2003). It has also been reported that ATP levels play a distinguishing role 
between apoptosis and necrosis; apoptosis is observed when the cells have a higher 
amount of ATP while necrosis is observed when ATP levels are low (Eguchi, Shimizu, & 
Tsujimoto, 1997; Los et al., 2002). Disruption of mitochondrial integrity prevents the 
production of ATP, and at the same time, disruption of plasma membrane causes the 
release of cellular contents which includes denatured proteins, DNA fragments, and other 
cellular debris into the extracellular compartment of the cell.  
However, depending upon the cell type, oxLDL-mediated cell death may be either 
caspase-dependent or -independent apoptotic pathways or via necrosis (Baird, Hampton, 
& Gieseg, 2004). Previous studies led by this laboratory discovered that THP-1 undergo 
caspase-mediated apoptosis whereas U937 cells depicted necrotic cell death due to the 
absence of caspase and no phosphatidylserine (PS) exposure (Baird et al., 2004). 
Moreover, a study done on HMDM cells revealed caspase-3 independent necrotic cell 
death (S. P. Gieseg, Amit, Yang, Shchepetkina, & Katouah, 2010; Shchepetkina, 2013). 
However, with the current research, we assume that oxLDL mediated–CHOP activation in 
U937 cells and human monocytes may lead to caspase-dependent or mitochondrial-
dependent apoptosis. We also question the ability of macrophage antioxidant 7,8–
dihydroneopterin (7,8-DNP) (Discussed in 1.7) in downregulating CHOP activation and 
preventing oxLDL–CHOP–mediated cell death in both cell lines.  
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1.4  Mitochondria and mitochondrial membrane 
potential. 
Mitochondria play a central role in cellular death mechanisms as it is the primary 
organelle involved in the cell’s response to apoptosis and signal transduction cascade 
(Green & Reed, 1998; Johnson & Boise, 1999). Mitochondrial membrane dysfunction is 
an early process before the changes in nuclear and plasma membranes. Mitochondria are 
responsible for translocating cytochrome c from the inner mitochondrial membrane 
(IMM) to the cytosol is an essential process in apoptotic signalling (Green & Reed, 1998; 
Majno & Joris, 1995; Patrice Xavier Petit et al., 1997; Tait & Green, 2010; Taylor et al., 
2008). Further release of cytochrome c activates caspases, causing apoptosis (detailed in 
1.3.1). The release of cytochrome c is related with the loss in mitochondrial membrane 
potential and permeability transition (PT) (Marzo et al., 1998; Patrice Xavier Petit et al., 
1997; Shimizu, Narita, & Tsujimoto, 1999). 
The changes in membrane dysfunctioning are marked by the increase in mitochondrial 
membrane permeability and loss in mitochondrial membrane potential (∆Ψm). 
Mitochondrial permeability transition pore (PTP) is the central regulator of loss in 
membrane potential (∆Ψm) and membrane permeability (Green & Reed, 1998). PTP 
complex is referred megachannel comprised of voltage-dependent anion channel (VDAC), 
inner membrane Adenine nucleotide translocators, i.e. adenine nucleotide translocase 
(ANT), cyclophilin D (cyPD) and peripheral benzodiazepine receptors (Figure 4) (Green 
& Reed, 1998; Patrice Xavier Petit et al., 1997). Cooperation of these multichannel 
proteins leads to the formation of large conductance channels which are accountable for 
mitochondrial permeability transition (PT) that may provoke apoptosis. The term was 
first coined by Hunter and Haworth in 1970s (Haworth & Hunter, 1979; Hunter, Haworth, 
& Southard, 1976; Hunter & Haworth, 1979). PT is described as a sudden elevation in 
inner mitochondrial membrane permeability to solutes (Ca2+, Mg2+, K+ ions) of molecular 
mass <1.5 kDa as a result the charge difference between mitochondrial matrix and cytosol 
(Bernardi, 1996; Gunter & Pfeiffer, 1990; Ichas & Mazat, 1998; Zoratti & Szabò, 1995). As 
the PTP pore is opened, the solutes and water cause the mitochondrial matrix to swell, 
repturing outer mitochondrial membrane (OMM) along with mitochondrial proteins 
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(Kroemer, 1997). This quick change in the permeability is conjugated with PT resulting 
in depolarization of membrane, uncoupled oxidative photophosphorylation, the release 
of intramitochondrial ions, metabolic intermediates and large swelling of mitochondria 
(Green & Reed, 1998; Patrice Xavier Petit et al., 1997; Zoratti & Szabò, 1995).  
 
Figure 4: Mitochondrial permeability transition pore (PTP) regulation taken from 
(Abou-Sleiman, Muqit, & Wood, 2006). 
1.5  Mitochondrial permeability transition pore (PTP) 
regulation. 
The opening of PTP is controlled by mitochondrial membrane potential (∆Ψm) and the 
pH of the mitochondrial matrix. The chances of opening pore increase when the 
mitochondrial matrix undergo acidification with the reduction in pH below 7.0 and 
decrease in ∆Ψm (Bernardi et al., 1992). The PTP is administered in 3 different 
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conditions; i) closed condition where ∆Ψm is integrated, ii) low conductance state, where 
the pore is partially opened, permeable to molecules <300 Da followed by the reversible 
decrease in ∆Ψm and iii) high conductance state, a condition characterised by the 
irreversible flip in the pore from the state of high conductance to state of low conductance 
accompanied by the irreversible collapse in ∆Ψm allowing permeability to molecules 
<1.5 kDa (Bernardi et al., 1992). During normal functioning of mitochondria, the PTP is 
impermeable in such a way that proper ∆Ψm is maintained for cell survival as it is 
responsible for ATP synthesis and oxidative phosphorylation (Gottlieb, 2001). This state 
of high conductance is essential for initiation of apoptosis (Zamzami et al., 1995).  
1.5.1 PTP opening models and cytochrome c release causing 
apoptosis. 
Several models of PTP opening have been proposed that dismantle ∆Ψm that are involved 
in the cytochrome c release so causing apoptosis via caspase activation. 
1.5.1.1 PTP induced mitochondrial swelling model (VDAC opening 
model) 
The model is characterized by the swelling and rupturing of the outer mitochondrial 
membrane that has been observed with different inducing agents (Scarlett & Murphy, 
1997; Zamzami et al., 1995) (Figure 5). Apoptosis inducers are directly linked with PTP 
causing the pore to open along with rapid depolarization and mitochondrial matrix 
swelling (Waring & Beaver, 1996). 
 
Figure 5: VDAC opening model taken from (Ly, Grubb, & Lawen, 2003). 
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1.5.1.2 PTP non-swelling model. 
The model suggests that low concentrations of Bax or Bid can induce mitochondria to 
release cytochrome c without mitochondrial matrix swelling or its rupture (Jürgensmeier 
et al., 1998). It was also observed that PTP opening without mitochondrial matrix 
swelling causes ∆Ψm to collapse through proton degeneration pathway causing Bax to 
undergo conformational change and its translocation to mitochondrial membrane to 
release cytochrome c  and trigger apoptosis (Jürgensmeier et al., 1998; Pastorino et al., 
1999) (Figure 6).  
 
Figure 6: PTP non-swelling model taken from (Ly et al., 2003). 
1.5.1.3 Formation of conducting channels. 
Numerous studies suggested the formation of conducting channels along with a non-
specific rupture of the outer membrane causes apoptosis (ANTONSSON, MONTESSUIT, 
LAUPER, ESKES, & MARTINOU, 2000; De Giorgi et al., 2002). The model also illustrates 
that the mitochondrial membrane rupture is a result of specific apoptotic proteins which 
later causes mitochondria to release cytochrome c. It is also known that this model 
system leads to the formation of the Bax-lipidic pore and Bax-VDAC channels 
(ANTONSSON et al., 2000; De Giorgi et al., 2002; Marzo et al., 1998; Shimizu, Ide, 




Figure 7: Formation of conducting channels taken from (Ly et al., 2003). 
1.6  Mitochondrial membrane potential (∆Ψm) and 
apoptosis. 
1.6.1 Calcium and mitochondrial membrane potential (∆Ψm). 
Cellular metabolism and apoptosis regulation are the critical roles played by 
mitochondria and the alterations in the cellular functions maintained by mitochondria is 
associated with apoptosis. This includes the collapse in of ∆Ψm, ROS accumulation, 
membrane PT and release of apoptotic factors (BCL-2 family protein members) into 
mitochondrial membrane and intermembranal space (cytochrome c) (Gottlieb, 2001). 
Mitochondria have long known to play an essential role in handling calcium load and are 
capable of sequestering Ca2+ through mitochondrial uniporter, using mitochondrial 
membrane potential to enhance the uptake of Ca2+ in higher amounts (De Stefani, 
Raffaello, Teardo, Szabò, & Rizzuto, 2011; Kirichok, Krapivinsky, & Clapham, 2004; 
Lawrie, Rizzuto, Pozzan, & Simpson, 1996). Due to their role in calcium homeostasis, they 
are also referred as capacitors.  
Alterations in the calcium homeostasis can lead to an elevation in cytosolic free calcium 
and lead to apoptosis through classical pore transition (PT) (Crompton, 1999; Rasola & 
Bernardi, 2007). Ca2+ overload in mitochondria can activate the opening of mitochondrial 
permeability transition pore (PTP) that further causes mitochondrial permeability 
transition (PT). Therefore when the apoptosis-inducing agents are introduced into the 
cellular system, the intracellular cytoplasmic Ca2+ levels are elevated resulting in 
primitive dispersion of ∆Ψm prior to the activation of caspases (Koya et al., 2000; I. 
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Kruman, Guo, & Mattson, 1998; I. I. Kruman & Mattson, 1999). Apoptosis induced calcium 
ionophores or TG can be blocked by intracellular calcium chelators by decreasing the 
calcium concentration below the concentration that is required to activate PTP (Koya et 
al., 2000; I. I. Kruman & Mattson, 1999). Izani (2015) observed that the cytosolic Ca2+ 
elevation induced by the calcium ionophore A2318 (BrA) resulted in loss of cell viability 
when the cells were incubated with 5 µM BrA and above. The following loss in cell 
viability was also observed by Yang (2009) when the BrA concentration was 5µM and 
above decreasing the viable cells up to 50% compared to cell only control within 5 
minutes of treatment. However, when the lower concentrations of BrA (3 µM) was 
introduced, it did not cause any significant loss in cell viability within 24 hours of 
treatment suggesting that intracellular concentration of Ca2+ in the cytosol is required to 
cause the cellular death.  
1.6.2 Mitochondrial membrane potential (∆Ψm) and 
cytochrome c release. 
Mitochondrial potential and PT play a vital role in the release of cytochrome c. However, 
PT inhibitors inhibit both apoptosis and cytochrome c release. The role of PT in apoptosis 
is still debated and is suggested that cytochrome c release and no loss in ∆Ψm is also an 
event responsible for cell death processes (J. Yang et al., 1997). However, there are 
evidences that directly supports the involvement of loss of ∆Ψm in releasing cytochrome 
c. Various studies suggested that PT and cytochrome c release are highly associated 
processes and the cytochrome c release occurs via PT through mitochondrial swelling 
and subsequent rupture of OMM (Patrice X Petit et al., 1998; Scarlett & Murphy, 1997). 
Rat hepatocytes underwent apoptosis induced by microstatin-LT during which a 
substantial loss in ∆Ψm was observed along with cytochrome c release and PT activation 
(Ding, Shen, & Ong, 2002). This was also observed in cultured cortical neurons which 
activated PT, rupturing OMM and releasing cytochrome c (Brustovetsky, Brustovetsky, 
Jemmerson, & Dubinsky, 2002). A drop in ∆Ψm and cytochrome c release was observed 
in PC6 cells when treated with Staurosporine (Heiskanen, Bhat, Wang, Ma, & Nieminen, 
1999). However, when ∆Ψm was inhibited by Bongkrekic acid (BA), it prevented 
cytochrome c release from dexamethasone (DEX) treated thymocytes suggesting 
correlation of ∆Ψm with cytochrome c release (Yoshino et al., 2001). 
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In contrast, there are also evidences that suggested the cytochrome c release is 
independent of changes or loss of mitochondrial membrane potential. This finding was 
supported by the study done on human monocyte-like THP-1 cells where cytochrome c 
release occurred before outer mitochondrial membrane rupture (Zhuang, Dinsdale, & 
Cohen, 1998). This was also followed by the finding in a cell-free system where 
cytochrome c release was not accompanied by changes in ∆Ψm during apoptosis 
suggesting that there was no involvement of PT activation (Kluck, Bossy-Wetzel, Green, 
& Newmeyer, 1997). Interestingly, involvement of Bcl-2 family member proteins (BH3-
only, Bid and Bik) resulted in cytochrome c release without any changes in ∆Ψm and PT 
activation (Shimizu & Tsujimoto, 2000; Von Ahsen et al., 2000). Overall these evidences 
suggests that the ∆Ψm play the role of a double-edged sword in releasing cytochrome c 
and further activating PT leading apoptotic cell death.  
1.7  7, 8–dihydroneopterin (7, 8–DNP) 
1.7.1 Neopterin and 7,8-DNP Synthesis.  
7, 8–DNP is a pterin synthesized by ϒ–interferon (INF-γ) activated macrophages (Figure 
8) (Müller, Curtius, Herold, & Huber, 1991) and its oxidation leads to the formation of 
different products including neopterin (Figure 8). Plasma neopterin is a highly 
fluorescent compound whose quantity in plasma has been used as a potential marker of 
inflammation (S. P. Gieseg, Crone, Flavall, & Amit, 2008) and a reliable indicator of plaque 
stability and prognosis (Liu & Li, 2013), in vascular disease (S. P. Gieseg et al., 2010; 
Janmale et al., 2015). Both neopterin and 7,8-DNP belong to a class of pteridines which 
are characterised by the presence of pyrazino-2,3-pyrimidine bicyclic nitrogen ring 
system (Wachter et al., 1992). Upon further classification, pteridines can be sub-classified 
depending on the oxidation state into fully reduced tetrahydropterins and partially 
reduced dihydroneopterins and aromatic pterins (K Oettl & Reibnegger, 2002).  
All members of pteridine class of compounds are synthesized from guanosine 
triphosphate (GTP). Upon stimulation of INF-γ, the enzyme GTP cyclohydrolase 1 
metabolises GTP into 7,8-NP triphosphate (Werner et al., 1990). Further, 7,8-DNP is 
generated from 7,8-NP triphosphate by the action of phosphatase enzymes (Wachter et 
al., 1992). Synthesis is also enhanced upon co-stimulation of tumor necrotic factor-α 
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(TNF-α), dexamethasone (DEX) or lipopolysaccharides (LPS) although not as stong as 
stimulated by TNF-α (Werner-Felmayer et al., 1995; Werner-Felmayer et al., 1990). Later, 
breakdown of 7,8-NP after its reaction with oxidant species results formation of 
neopterin, 7,8-dihydroxanthopterin and xanthopterin.  
 
Figure 8: Synthesis of 7, 8-DNP. 
1.7.2 Antioxidant potential of 7,8-DNP.  
Reduced pteridines such as 7, 8-DNP are well-known for their antioxidant potential 
(Rezk, Haenen, van der Vijgh, & Bast, 2003) and are produced by the macrophages in the 
plaque. In vitro studies have shown the ability of 7, 8-DNP in inhibiting LDL oxidation (S. 
P. Gieseg, Reibnegger, Wachter, & Esterbauer, 1995), inhibiting ROS mediated reactions 
(Karl Oettl, Greilberger, Dikalov, & Reibnegger, 2004), and preventing free radical 
damage including hydroxyl and peroxyl radicals (Duggan, Rait, Platt, & Gieseg, 2002); 
suggesting the antioxidant effect of 7, 8-DNP. 7, 8-DNP is an efficient scavenger of 
superoxide and peroxyl radicals generated by 2,2'-azobis-2-methyl-propanimidamide, 
dihydrochloride (AAPH) (Karl Oettl et al., 2004) while also reacting with hydrogen 
peroxide (H2O2) and chlorine species such as chloramine-T (Weiss et al., 1993). The 
reaction rate of 7, 8-DNP with AAPH which nears its rate of diffusion makes it a good 
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inhibitor of peroxyl radical damage (Duggan et al., 2002; S. Gieseg, Duggan, & Gebicki, 
2000). 7, 8-DNP has also been shown the inhibition of AAPH driven oxidation of 
polyunsaturated omega-6 fatty acid linoleate along with the formation of diene on LDL 
molecules during AAPH as well as copper mediated LDL oxidation (S. P. Gieseg et al., 
1995). 7, 8-DNP protects bovine serum albumin (BSA) against AAPH-driven oxidation (S. 
P. Gieseg et al., 1995). 
7, 8-DNP can also inhibit erythrocyte lysis caused by HOCl, H2O2 and AAPH treatments (S. 
P. Gieseg, Maghzal, & Glubb, 2001; Y. T. Yang, Whiteman, & Gieseg, 2012). The degree of 
protection varied as 7, 8-DNP provided a complete protection during AAPH mediated 
oxidation, while providing partial protection (40%) when oxidation was driven by H202 
(S. P. Gieseg et al., 2001). Further studies confirmed this effect of 7, 8-DNP in protein 
hydroxide and lipid peroxide formation on LDL slowed down in HMDM and THP-1 cells 
(Firth, Crone, Flavall, Roake, & Gieseg, 2008). Overall the evidence suggests that 7, 8-DNP 
can act as an antioxidant which is capable of protecting cells from oxidative damage. 
1.7.3 Role of 7, 8-DNP on cell survival and viability. 
The research studies carried by this laboratory over the years targeted at determining 
whether the antioxidant potential of 7, 8-DNP is sufficient for cell survival and viability. 
A biologically relevant study has demonstrated the protective role of 7, 8-DNP on oxLDL 
induced cytotoxicity on the cells from myelocytic origins. It has also been reported that 
micromolar concentrations of 7, 8-DNP inhibited oxLDL toxicity to U937 cells (Baird, 
Reid, Hampton, & Gieseg, 2005), THP-1 and HMDM cells (S. P. Gieseg & Cato, 2003).  
Conversely, other studies also found the non-protective effect of 7,8-DNP where high 7,8-
DNP concentrations induced apoptotic cell death. The study reported that L2 cells 
experienced 17% and 13% apoptosis when treated with 100 µM 7,8-DNP and neopterin 
(Schobersberger et al., 1996) while exibiting higher cytokines TNF-α and INF-γ to get the 
effect. It was also observed that cells underwent apoptosis when treated with 5 mM 7,8-
DNP (Wirleitner, Baier-Bitterlich, Böck, Widner, & Fuchs, 1998). Later it was suggested 
that 7,8-DNP generated by overproduction of free radicals might be a possible factor for 
its apoptotic effects (Wirleitner et al., 2001). 
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In contrast to above evidences, a study led by Bratslavsta et. al (2007) showed that 
neopterin and 7, 8-DNP had no effect on cell viability in Hep-G2 cells (Bratslavska, Platace, 
Miklaševičs, Fuchs, & Martinsons, 2007). However, no adverse effect of 7, 8-DNP (upto 
300 µM) on cell viability of U937, THP-1 or HMDM cells was observed in our laboratory. 
The described effects may be determined by the tolerance of different cell lines 
responding to the disturbances in the intracellular redox balance. 
Based on the following activities of 7,8-DNP, we also hypothesize that macrophage 
antioxidant 7, 8–DNP would block macrophage activation of CHOP and prevent CHOP–
mediated cell death in U937 cells in the presence of oxLDL as NOX activation appears to 
be a crucial part of unfolded protein response. 
1.8 Research Goals 
Endoplasmic reticulum stress is a well-studied mechanism which causes cell death 
through activation of various pathways (Oyadomari & Mori, 2004; Scull & Tabas, 2011; 
Tu & Weissman, 2004; Xu, Bailly-Maitre, & Reed, 2005). In this research, we aimed at 
observing the expression of an essential ER-stress marker CHOP (Oyadomari & Mori, 
2004) in mediating cell death. It is also known that oxidized LDL is also known to trigger 
CHOP mediated cell death (Shutong Yao, 2014; Tao et al., 2009). Hence one of the critical 
goals of the research is to observe oxLDL mediated CHOP activation in U937 cells.  
The initial section of Chapter Three (3.1) will determine the toxic effect of Cu-oxLDL on 
U937 cell viability. The cell viability obtained from different Cu-oxLDL batches will help 
in examining the LC50 concentrations throughout the research, and further objectives will 
be carried out based on LC50 concentrations obtained. The viability will be examined by 
both PI flow cytometry and MTT colorimetric assay.  
The second part of the study will focus on determining the cytotoxic effect of SERCA 
inhibitor Thapsigargin (TG) on U937 cells. The cytotoxic effect of TG will again be 
determined using PI flow cytometry, and MTT colorimetry assay and LC50 concentration 
will be calculated (3.2). Thapsigargin is also known to activate apoptotic cell death in 
various cell lines, so to investigate this, the research will further assess the changes in 
mitochondrial membrane potential by staining the cells by TMRM which will be analyzed 
by flow cytometry (3.3). The next section of Chapter 3 (3.4) will investigate the potency 
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of ER-stress inducer TG in triggering CHOP activation in U937 cells. CHOP is main ER-
stress marker and is expressed when the cell experiences ER-stress. Western blotting will 
investigate the expression of TG-induced ER-stress.  
Numerous studies till date have shown the capacity of 7, 8-DNP to protect the cells from 
cytotoxic effect of oxLDL (Baird et al., 2005; S. P. Gieseg et al., 2010; S. P. Gieseg et al., 
2001). However, the effect of 7, 8-DNP on CHOP upregulation/downregulation is not yet 
seen. Based on the protective effect of 7, 8-DNP we will examine the effect of antioxidant 
7, 8-DNP neopterin CHOP activation in U937 cells. 3.5 part of Chapter 3 will emphasize 
the antioxidant effect of macrophage stimulated antioxidant 7, 8-DNP on CHOP activation 
by western blotting technique.  
One of the principal goals of the research program is to investigate the potential of oxLDL 
in inducing Cu-oxLDL-induced CHOP expression in U937 cells. This part of Chapter 3 
(3.6) will examine the role of Cu-oxLDL in triggering CHOP activation in Dose (3.6) and 
time-dependent manner (3.7). Western blotting will examine the investigation of CHOP 
expression.  
ACAT (cholesterol esterase enzyme) is the responsible enzyme for the conversion of FC 
to CE. ACAT inhibitors have reported reducing foam cell and atheroma formation (Bocan 
et al., 2000; Bocan et al., 1993; Kusunoki et al., 2001). The present study has utilized the 
novel ACAT inhibitor Sandoz 58-035. 3.8 and 3.9 sections of Chapter Three to determine 
the effectiveness of ACAT inhibitor on Cu-oxLDL (3.8) treated cells and the toxicity of 
ACAT inhibitor alone (3.9) using PI flow cytometry and MTT colorimetric assay. 
The last part of Chapter 3 will address some preliminary work investigations looking at 





2 MATERIALS AND METHODS 
2.1  Materials 
2.1.1 Reagents 
Experiments throughout the research were carried out using reagents of analytical grade 
or better. Water was deionized and ultra-filtered using a Milli-Q filtration water system 
and all solutions were prepared using this nanopure water. 
 
β–mercaptoethanol Sigma Chemical Co., Missouri, USA 
3–[4,5–Dimethylthiazol–2–yl]–2,5–
diphenyl-tetrazolium bromide (MTT) 
Sigma Chemical Co., Missouri, USA 
4–Morpholine–propanesulfonic acid 
(MOPS) 
Sigma Chemical Co., Missouri, USA 
7, 8–Dihydroneopterin (7,8–DNP) Schircks Laboratory, Switzerland 
Acetic acid (glacial)  
Acetone Merck Ltd, Poole, England 
Non–fat milk powder Alpine 
Argon gas BOC Gases, Auckland, NZ 
Bicinchoninic acid (BCA) protein 
determination kit 
Pierce, Illinois, USA 
Bovine Serum Albumin (BSA) Gibco, Invitro Corporation, USA 
Bromophenol blue Sigma Chemical Co., Missouri, USA 
Chelex 100 resin Bio – Rad Laboratories, California, USA 
Cholesterol reagent Roche Diagnostics, USA 
Copper chloride (CuCl2) Sigma Chemical Co., Missouri, USA 
Coumassie blue R stain Sigma Chemical Co., Missouri, USA 
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Dimethyl sulphoxide (DMSO) BDH Laboratory Supplies Ltd., Poole, 
England 
Dulbecco’s Phosphate Buffered Saline 
(PBS) 
Sigma Aldrich, UK 
Ethanol Fisher Chemicals 
Ethylenediaminetetraacetic acid (EDTA) Sigma Chemical Co., Missouri, USA 
Hydrochloric acid, fuming 37 % Merck, Darmstadt, Germany 
Isopropanol Fisher Chemicals 
Methanol Fisher Chemicals 
Molecular Weight Marker Thermofisher Scientific  
Nitrogen gas BOC Gases, Auckland, NZ 
NuPAGE 4–12 % Bis–tris Gel, 1.5 mm X 10 
well 
Invitrogen, Oregon, USA 
Ponceau S Sigma Chemical Co., Missouri, USA 
Potassium bromide (KBr) Sigma Chemical Co., Missouri, USA 
Potassium dihydrogen phosphate 
(KH2PO4) 
Fisher Chemicals 
Propidium Iodide (PI) Sigma Chemical Co., Missouri, USA 
Sandoz 58–035 (ACAT Inhibitor) Sigma Chemical Co., Missouri, USA 
Sodium chloride (NaCl) VWR, Life technologies Ltd. 
Sodium dihydrogen orthophosphate 
monohydrate (NaH2PO4.H2O) 
Scharlau, Spain 
Sodium dodecyl sulphate (SDS) Sigma Chemical Co., Missouri, USA 
Sodium hydroxide (NaOH)  
Supersignal west Dura 
chemiluminescence 
Pierce Biotechnology Inc., Illinois, USA 
Thapsigargin Sigma Chemical Co., Missouri, USA 
Thimerosal Sigma Chemical Co., Missouri, USA 
Tetramethylrhodamine methyl ester 
(TMRM) 
Merck Darmstadt, Germany 
Tris Sigma Chemical Co., Missouri, USA 
Triton–X 100 Sigma Chemical Co., Missouri, USA 
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Trypan blue solution (0.4 %) Sigma Chemical Co., Missouri, USA 




Fetal bovine serum Sigma Chemical Co., Missouri, USA 
Penicillin/Streptomycin (10000 units/mL 
Penicillin G and 10000 units/mL 
Streptomycin) 
Gibco by life Technology, USA 
Roswell Park Memorial Institute (RPMI)–
1640 Media with phenol red  
Hyclone, GE Healthcare Life Sciences, Utah 
Roswell Park Memorial Institute (RPMI)–
1640 Media without phenol red 
Gibco by life technology, USA 
 
2.1.3 Antibodies 
GADD 153 (B–3) mouse monoclonal IgG1 қ Santa Cruz Biotechnology Inc., USA  
Mouse monoclonal against β – actin  Sigma – Aldrich Chemicals Co., USA 





2.2  General solutions and buffers 
2.2.1 Phosphate buffered saline (PBS) 
Phosphate buffered saline consisted 150 mM sodium chloride (NaCl, MW= 58.44 g/mol) 
to 10 mM sodium dihydrogen phosphate at pH 7.4 (NaH2PO4.H2O, MW= 137.99 g/mol). A 
liter of PBS was prepared by adding 50 mL of 3M NaCl, 40 mL of 250 mM NaH2PO4.H2O 
(pH 7.4) to 910 mL of Nano-pure water. PBS solution for cell culture work was vacuum 
filtered through 0.45 μm membrane and sterilized by autoclaving for 15 minutes, 1210C 
and 15 psi. PBS was warmed in water bath at 37oC in water bath prior to use with cells. 
2.2.2 MTT assay solution 
MTT (3–[4,5–Dimethylthiazol–2–yl]–2,5–diphenyl-tetrazolium bromide) stock solution 
was prepared by dissolving MTT powder (Sigma Chemical Co., Missouri, USA) in RPMI 
1640 without phenol red to give the final concentration at 5 mg/mL. This solution was 
filtered sterilized using a 0.22 μm MS® PES syringe filter and stored at -200C in the dark 
until further use. For viability assay, the stock solution was used to give final 
concentration at 0.5 mg/mL. 
A 10% SDS in 0.01 M HCl was made up from 11.44 M HCl and Nano–pure water. Sodium 
dodecyl sulphate (SDS) powder was added to 0.01 M HCl solution and stirred up slowly 
to give a final concentration at 10% (w/v) SDS.  
2.2.3 ACAT inhibitor stock solution 
Sandoz 58–035 (ACAT inhibitor) (Sigma Chemical Co., Missouri, USA) stock solution was 
prepared by dissolving Sandoz 58–035 powder in DMSO (BDH Laboratory Supplies Ltd., 
Poole, England) to give the final concentration at 5 mg/mL. The solution was filtered 
sterilized using a 0.22 μm MS® PES Syringe filter and stored at 40C until use. 
2.2.4 Propidium iodide stock solution 
A 1 mg/mL stock solution was prepared by dissolving propidium iodide (PI) powder 
(Sigma Chemical Co., Missouri, USA) in sterile nanopure water to give the final 
concentration of at 1.5 μg/mL. The solution was filtered sterilized using a 0.22 μm MS® 
PES syringe filter and was stored at 40C until further use. 
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2.2.5 7, 8–dihydroneopterin (7, 8-DNP) solution 
A 2 mM stock solution of 7, 8–DNP (MW= 255.2 g/mol) was prepared fresh every time 
immediately before each experiment. 7, 8-DNP powder (Schircks Laboratory, 
Switzerland) was dissolved in appropriate medium followed by 10–15 minutes 
ultrasonication. The 7, 8–DNP solution was then filtered–sterilized using a 0.22 μm MS® 
PES Syringe filter and diluted to working concentrations before added to cells. The 
solution was kept on ice at all times. 
2.3  Methods 
2.3.1 Cell Culture 
All cell culture work and experiments were performed in aseptic conditions in Class II 
biological safety cabinet (ScanLaf, Labgene APS, Denmark). All equipment and plastic 
wares were supplied sterile, ready to use and disposable. All media and solutions 
prepared were sterilized either by autoclaving or by filtering through sterile 0.22 μm 
membrane filter. All equipment and tissue culture items were sprayed thoroughly by 
70% ethanol before being used in CII biological safety cabinet. Cells were incubated in an 
incubator at 370C in humified atmosphere containing 5% CO2. 
2.3.2 Cell culture media 
Cell culture media with varying chemical compositions were used for cell culture 
depending on the compatibility of cells and environmental conditions. In the current 
study, RPMI–1640 medium was used in culture of U937 cell line and human monocytes. 
2.3.3 Standard RPMI-1640 media 
RPMI-1640 medium with phenol red (Hyclone, GE Healthcare Life Sciences, Utah) 
supplemented with 100 U/mL penicillin G, 100 U/mL streptomycin and 5% fetal bovine 
serum (FBS) was utilized for normal U937 cell sustenance. However, for human 




2.3.4 RPMI–1640 without phenol red 
RPMI 1640 without phenol red (Gibco by life technology, USA) was aliquoted in 50 mL 
falcon tubes and were used for experiments with and without 5% fetal bovine serum as 
stated for individual procedure. 
2.4  Cell culture experimental conditions and protocols 
Experiments were performed using either 12–well or 24 well suspension culture plates 
depending upon the number of treatments or total volumes for both U937 cells (with or 
without serum) and human monocytes unless otherwise stated. The wells of plates were 
coated with 1 mL albumin (1.25 mg/mL) (Gibco, Invitro Corporation, USA), were left 
undisturbed for 2–3 minutes until dried and were later used for experiments when 
performing experiments in absence of serum. 
Cells were counted using a hemocytometer and a light microscope after staining with 
trypan blue at a ratio of 1: 1 (2 times dilution) for U937 cells whereas 1: 9 (10 times 
dilution) ratio for human monocytes. The required quantity was cells for the experiments 
was centrifuged at 500 g for 5 minutes at room temperature and was re-suspended in 
appropriated experimental medium at 370C. The cell concentration was the aliquoted 
into wells containing the medium at a concentration of either 0.5 × 106 cells/mL or 1 × 
106 cells/mL for U937 cells or human monocytes. 
2.5  Preparation of culture of human monocytes 
Unlinked blood from the healthy consenting haemochromatosis individuals were 
collected into a 500 mL autologous blood bag containing anticoagulant by New Zealand 
Blood Service (NZBS) Riccarton branch, Christchurch. The cells were immediately 
prepared after blood collection or kept for up to 18 hours at 40C if processing cannot be 
carried out on the same day.  
The bag of whole blood was inverted gently for 10–12 times to ensure evening mixing 
and distribution of cells and other components before placing the bag in to the CII safety 
cabinet aseptically. One of the bag tube was cut opened using scissors and blood was 
transferred to 50 mL falcon tubes and were centrifuged at 1000 g with fast acceleration 
and slow deceleration for 20 minutes. After centrifugation, the cells were separated into 
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few layers consisting of erythrocytes at the bottom, topped with white layer of leucocytes 
(buffy coat) and overlaid with the plasma layer. The plasma layer was aspirated leaving 
the leucocytes layer which was removed using a mixing cannula attached to a 10 mL 
plastic syringe, pooled and mixed with equal volume of Dulbecco’s PBS (Sigma Aldrich, 
UK) by inverting thoroughly. The mixture was then underlaid by 15 mL Lymphoprep® 
(Lymphoprep) using a mixing cannula attached to a 20 mL syringe before being 
centrifuged again at 1000 g (with brakes off and soft start) for 20 minutes at room 
temperature. The resulting white layer of monocytes/lymphocytes was visible halfway 
down 50 mL tube encircled by clear plasma and Lymphoprep layers. The top layer 
solution layer was aspirated leaving above the leucocyte layer. 
The cells in solution was transferred in new 50 mL falcon tubes using a mixing cannula 
attached to a syringe and thoroughly re-suspended and evenly divided between a 
designated number of tubes with each containing approximately 15 mL solution. Later, 
PBS was topped up to a final volume of 50 mL, was mixed by inverting before being 
centrifuged at 500 g for 15 minutes. The pellet was re–suspended in 5 mL sterile MiliQ 
water for 10-12 seconds was topped up again with PBS up to the final volume of 50 mL 
and was centrifuged again at 500 g for 15 minutes if the pellet consisted of erythrocytes. 
The washing step with PBS was repeated once more before the cells were re–suspended 
in the RPMI–1640 media containing Penicillin/streptomycin without serum. The cells 
were then plated into 6–well suspension plates (CellStar, Greiner Bio-one, Germany) and 
incubated in the CO2 incubator for 40 hours.  
2.6  Preparation of human serum for cell culture  
Human serum from haemochromatosis blood donors was used for cell culture of human 
monocytes under ethics approval CTY/98/07/069 approved by Upper South (B) regional 
Ethics committee. Unlinked blood from heathy consenting donors was collected into 450 
mL dry bags (without anticoagulant) by New Zealand Blood Service (NZBS) Riccarton 
branch, Christchurch. The blood bag was left in the vertical position in polypropylene 
container at room temperature for 2 hours to allow blood clot. The blood bag was later 
transferred to 40C fridge and stored overnight to grant sufficient time for separation of 
serum from clot.  
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The blood bag was opened in CII cabinet under sterile conditions and serum was pooled 
in 50 mL falcon tubes using a mixing cannula attached to a syringe, leaving blood clot at 
the bottom of bag. The tubes were centrifuged at 1500 g at room temperature for 15 
minutes. The centrifugation step was repeated if the serum appeared red after first 
centrifugation. The serum was transferred into fresh sterile falcon tubes leaving the pellet 
behind. The serum was then cooled at 40C, transferred to -200C for freezing and finally to 
–800C for long term storage. This human serum was supplied to human monocytes at 
10% final concentration.  
2.7  Isolation and oxidation of LDL  
2.7.1 Collecting human blood for plasma preparation 
Blood (200 mL) was drawn from healthy donor by venipuncture using an 18G butterfly 
needle and a syringe after an overnight fast. The blood was collected directly into a 50 mL 
falcon tube with 0.5 mL 10% EDTA pH at 7.4 so that the final concentration of EDTA in 
blood was 0.1%. The blood was centrifuged at 4,100 g for 20 minutes at 40C with a soft 
start and stop. The supernatant was transferred to white 50 mL high speed centrifuge 
tubes for a fixed angle rotor followed by centrifugation at 11,000 g for 30 minutes with 
soft start button on. However, centrifugation was proceeded at 5,000 rpm for first 5 
minutes and was later switched to 13,000 rpm for next 20 minutes using a SS34 rotor 
centrifuge. After the centrifugation, the plasma was pooled and collected into a single 
cylinder by pouring it from the centrifuge tube leaving the pellet intact in the centrifuge 
tube. The volume of pooled plasma was recorded and was aliquoted in 32 mL lots in a 50 
mL falcon tube. The pooled plasma was cooled at 40C, moved to -200C for freezing and 
was finally transferred to –800C for long term storage. 
2.7.2 LDL preparation from plasma by gradient centrifugation 
LDL was prepared using modified Beckman NVTi65 Rotor method as described by Gieseg 
and Esterbauer (1994). In general, the method separates lipid types based on their 
gradient. EDTA–plasma tube was defrosted in the running cold water. Centrifuge was 
cooled at 40C until the plasma was defrosted. The plasma was further centrifuged at 4,700 
g for 10 minutes at 40C. The supernatant was transferred into the beaker placed on the 
ice, adjusting the plasma density at 1.3 by slowly adding 381.8 mg of KBr per mL of 
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plasma. The solution was gently stirred to dissolve KBr allowing less amount of froth 
formation. In meanwhile, 1% EDTA pH 7.4 was degassed for 10 minutes in oxygen free 
nitrogen and 8 mL of this deoxygenated 1% EDTA was added to each of 8 ultracentrifuge 
tubes (OptiSeal™, Beckman Coulter, USA) before underlaying with 4 mL of KBr–Plasma 
using a longer lure–fitting needle attached to a 5 mL syringe. The tubes were transferred 
to NVTi65 rotor and centrifuged at 60,000 rpm for 2 hours and 40C with acceleration and 
deceleration. A yellow band (Figure 9) was observed was collected using a syringe 
attached to 900C–bent needle. 
 
Figure 9: LDL isolation 
 
2.7.3 LDL concentration 
LDL was concentrated using ultrafiltration centrifugation cartridges (Amicon, Ultra, 
Millipore Ireland Ltd., Ireland). Before using tubes for LDL concentration, they were 
rinsed thrice with nanopure water and then centrifuged with PBS for 2 minutes at 3000 
g to wash. After the wash, LDL was placed into these cartridges (20 mL), topped up with 
PBS and centrifuged at 3000 g at 40C for 20 minutes with fast acceleration and 
deceleration. This process was repeated twice to exclude remaining EDTA from the LDL. 
The purified LDL was concentrated using the same procedure by centrifuging for 10–20 
minutes, however, the centrifugation time varied depending upon the original 
concentration of the LDL which was later adjusted to final concentration of 10 mg/mL 
solution (total mass). After use, the membranes were rinsed with nanopure water, 
centrifuged with nanopure water for 2 minutes, then for 1 minute with 100% ethanol and 




2.7.4 LDL concentration determination 
Determination of LDL concentration was done with respect to the total cholesterol mass 
which was measured by Cholesterol assay kit (Roche, Germany). The total cholesterol in 
the LDL was determined by incubating 1 mL of CHOL reagent with 10 µL of native LDL at 
room temperature. After 10 minutes, the absorbance was measured at 500 nm and LDL 
concentration was calculated based on estimation that LDL having molecular weight of 
2,500 KDa and cholesterol accounts for 31.69% of LDL particle by weight and total LDL 
mass relates to the mass of apoB–100 as 1:5 (S. P. Gieseg & Esterbauer, 1994). 
Calculation of LDL Concentration:  
Absorbance × 14.9 = [Cholesterol] (mM) 
[Cholesterol] (M) × 368.64 g/mol = [Cholesterol] (g/L) 
[Cholesterol] (g/L) × 100/31.69 = [LDL] (g/L or mg/mL) 
2.8  Preparation of oxidized LDL 
2.8.1 Dialysis tubing preparation for oxidation of LDL 
The dialysis membrane tubing (Medical International Ltd., London, England) was cut into 
25 cm sections and were boiled in 1 mM EDTA and 5% (w/v) NaHCO3 for 20 minutes. The 
tubes were washed with nanopure water and boiled again in nanopure water for 20 
minutes. The tubes were again washed thoroughly with nanopure water and were stored 
for long term use in the solution containing water: ethanol (50:50, v/v) at 40C. The tubes 
were rinsed with water and PBS before being used for oxidation of LDL. 
2.8.2 LDL oxidation 
The concentrated native LDL was mixed with 0.5 mM CuCl2 placed in the double knotted 
dialysis tubing closed with a zip clip and a knot. The tubing was later placed in a loosely 
capped bottle containing PBS and 0.5 mM CuCl2, kept in 370C in shaking incubator for 24 
hours (Satchell & Leake, 2012). The amount of PBS was adjusted accordance to the 
amount of LDL to comprise 1L buffer/10 mg LDL. During this process, the yellow colored 
native LDL becomes colorless. After 24 hours, the dialysis bag was transferred to bottle 
containing 1L PBS and a teaspoon of washed Chelex-100 resins and magnetic flee at 40C. 
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The solution was left stirring for 2 hours at 40C after which the bag was transferred to a 
new bottle containing and Chelex and PBS for 2 more hours. The tubing was left 
undisturbed overnight after transferring the tubing into the new bottle containing PBS 
and Chelex. The following day oxLDL was separated from dialysis tubing and was filter-
sterilized through a 0.22 µm membrane filter in the CII cabinet, stored at 40C and was 
used within 2 months from time of oxidation. 
2.9  Biochemical analysis 
2.9.1 Protein concentration determination 
Bicincronic acid (BCA) protein analysis kit (Thermo Scientific, Rockford, USA) was used 
to estimate the protein concentration in the samples. The method is the combination of 
reduction of Cu2+ ions to Cu+ ions in alkaline medium and calorimetric determination of 
Cu+ ions using bicincronic acid. 
Sample preparation: The working reagent for BCA assay was freshly prepared by 
mixing Reagent A and Reagent B of the kit in 50: 1 ratio. 1 mL of working reagent was 
mixed with 50 µL of diluted sample and incubated at 600C for 30 minutes with gentle 
shaking. The reaction was stopped by either placing samples on ice or partially 
immersing them in the cool water for no longer than 2 minutes. The protein 
concentration was determined by reading absorbance at 562 nm (Agilent Technology) 
and was compared to standard curve prepared by the incubation of known BSA 
concentrations in 1 mL working reagent. 
2.10 Cell viability Assay 
2.10.1 MTT reduction Assay 
The MTT colorimetric assay determined the ability of viable cells to convert soluble 
tetrazolium salt (MTT) into insoluble formazan precipitate. Tetrazolium salts accepts 
electrons from oxidized substrates or appropriate enzymes such as NADH and NADPH. 
MTT is reduced by ubiquinone, cytochrome b and c sites of mitochondrial electron 
transport chain and is a result of succinate dehydrogenase activity. This reaction converts 
yellow salts to blue colored formazan crystals that can be dissolved in an organic solvent 
whose concentration can be spectrophotometrically determined (Mosmann, 1983). 
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Trypan blue exclusion assay is another widely used method to determine cell viability. 
Cell’s ability to exclude a colored dye (trypan blue) serves as a measure of membrane 
integrity thus indicating cell survival. 
Sample preparation for U937 cells: 500 µL of U937 suspension cells were seeded at 
concentration 2.5 × 106 cells/mL into 24 well suspension plates and were directly treated 
with 50 µL of 5 mg/mL MTT reagent into the treatment wells to obtain the final 
concentration of 0.5 mg/mL. The plates were incubated in the dark at 370C for 1–2 hours 
to allow sufficient formazan development. The formazan crystals were thoroughly mixed 
and solubilized by addition of equal volume (500 µL) of 10% (w/v) SDS in 0.01 M HCl into 
each well and the absorbance was quantified at 570 nm using (Agilent Technology) 
against the blank containing either the reagents only or nanopure water. The relative 






Sample preparation for human monocytes: 500 µL of human monocyte suspension 
cells were seeded at concentration 0.5 × 106 cells/mL into 24 well suspension plates and 
were directly treated with 50 µL of 5 mg/mL MTT reagent into the treatment wells to 
obtain the final concentration of 0.5 mg/mL. The plates were incubated in the dark at 
370C for 1–2 hours to allow sufficient formazan development. The formazan crystals were 
thoroughly mixed and solubilized by addition of equal volume (500 µL) of 10% (w/v) SDS 
in 0.01 M HCl into each well and the absorbance was quantified at 570 nm using (Agilent 
technology) against the blank containing either the reagents only or nanopure water. The 
relative percentage of viability was calculated as above. 
2.10.2 Trypan blue exclusion assay 
The suspension cells were mixed by pipetting and 100 µL was collected into a separate 
eppendorf tube followed by the addition of trypan blue at appropriate ratio (1: 1 for U937 




2.11 Flow Cytometry 
Flow cytometry gives quick analysis of numerous characteristics of single cells with both 
quantitative and qualitative information. Characteristics such as cell size, cell cycle, 
viability, cytoplasmic complexity, apoptosis nucleic contents, membrane potential and 
variety of membrane–bound and intracellular proteins can be measured using a flow 
cytometer. Flow cytometer Scatters light at various angles and distinguishes the cells 
based on its size and internal complexity whereas, light emitted from fluorescently 
labelled antibodies indicates a variety of cell surface and cytoplasmic antigens. An Accuri 
C6 flow cytometer (Accuri Cytometer, BD CSampler) was used to measure Propidium 
iodide, annexin V and TMRM probe fluorescence. 
2.11.1 PI staining and cell viability 
Externalization of PS (Phosphatidylserine) to the cell surface is an early marker of 
apoptotic cell death. PI (Propidium Iodide) a marker of membrane permeability, can be 
used to distinguish between early apoptosis and necrosis. Plasma membrane integrity is 
lost during both primary and secondary necrosis (necrosis occurs after apoptosis when 
apoptotic cells are not removed by phagocytosis), allowing Propidium Iodide to enter the 
cell and stain the nuclear material. 
Sample preparation: 500 µL of U937 suspension cells were seeded at concentration 2.5 
× 106 cells / mL into 24 well suspension plates and were directly treated with 8 μL of 1 
mg/mL PI to obtain the final concentration of 1.5 μg/mL and incubated in dark for 10–15 
minutes. After the incubation, the cells were analyzed using flow cytometer. 
Data Collection and gating: Data on U937 was collected by setting the flow rate at 66 
uL/minute with core size of 30 μm and a minimum 10,000 events into the gated area. The 
gate contained healthy cells, cell debris and early necrotic cells to determine the cell 
viability. FL3 filter was used which has excitation at (535 nm) and emission at (617 nm). 
Size was detected by forward scatter (FSC) and granularity by side scatter (SSC) using a 
dot plot by selecting a linear scale. Exclusion gates were set up based on FSC and SSC dot 
plot, cellular debris was excluded and a histogram was plotted to detect PI using a log 
scale. The data was collected using a CFlow plus software and analyzed. All the data was 
collected and examined using CFlow Plus software. 
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2.11.2 TMRM staining and mitochondria membrane 
potential 
Apoptosis can be indicated by loss of mitochondrial membrane potential which can be 
measured by cationic redistribution fluorescent dyes such as tetramethylrhodamine 
methyl ester (TMRM) (Merck Darmstadt, Germany) (Scaduto & Grotyohann, 1999; 
Shapiro, 1994). Carbonyl cyanide m-chlorophenyl hydrazone (CCCP) is a protonophore 
that depolarizes mitochondria, acting as a positive control for loss of membrane potential 
which eventually results in reduced TMRM staining. TMRM dye is lipophilic in nature and 
its molecular structure bear a positive charge which helps it to penetrate in negatively 
charged mitochondria. Upon its accumulation, it exhibits orange fluorescence. Non–
apoptotic cell or a healthy cell will exhibit a higher level of orange fluorescence as 
compared to the apoptotic cells. 
Sample preparation: 1 mL of U937 suspension cells were seeded at concentration 0.5 × 
106 cells / mL into 24 well suspension plates and apoptosis was induced by desirable 
method. Positive control cells were treated only with 1 μL of 50 mM CCCP to obtain the 
final concentration of 50 μM. Control and apoptosis–induced cells were treated with 5 μL 
10 μM TMRM to obtain the final concentration of 50 nM. The samples were incubated in 
dark for 20 minutes and were analyzed using flow cytometer. 
Data Collection and gating: Data on U937 cells was collected using following settings: 
Flow rate, 66 uL/minute; core size, 30 μm and volume, 30 μL with minimum 10,000 
events to be recorded. FL2 laser filter was used as TMRM maximally excites at ~550 nm 
and emits maximally at 575 nm (Lisa C. Crowley). Size was detected by forward scatter 
(FSC) and granularity by side scatter (SSC) using a dot plot by selecting a linear scale. 
Exclusion gates were set up based on FSC and SSC dot plot, cellular debris was excluded 
and a histogram was plotted to detect TMRM using a log scale. The data was collected 
using a CFlow plus software and analyzed. 
40 
 
2.12 Western blotting 
2.12.1 Solutions for western blot 
Cracker buffer: 125 mM Tris–HCl, 1% SDS (w/v), 20% glycerol (w/v), 0.1% 
bromophenol blue (w/v) were mixed in nanopure water and pH was adjusted to 6.8 using 
concentrated HCl. Prior to use 2% (v/v) β–mercaptoethanol and 0.5 mM EDTA was added 
to 1 mL of the above solution. 
Triton–X100 for cell lysis: The solution consisted of 1% triton X100, 7x minitab 
protease inhibitor cocktail and nanopure water. The cell lysis solution was prepared fresh 
prior to experiment and was stored in 40C until addition to samples to initiate cell lysis. 
MOPS buffer: A 10X stock solution of MOPS was prepared with 500 mM MOPs, 500 mM 
Tris base 1% SDS (w/v) and 10 mM EDTA in water with pH adjusted to 7.7. This 10X 
concentration was further diluted in nanopure water to 1X prior to use. 
Transfer buffer: Transfer buffer consisted of 25 mM Tris, 200 mM Glycine, and 20% 
methanol (v/v) in nanopure water and was stored at 40C for further use. 
Tris buffered saline (TBS): 1X Tris buffered saline was prepared from 10X stock for 
nitrocellulose washing consisted of 40 mM Tris–HCl, 150 mM NaCl at pH 7.5, 0.1% 
Tween20 (w/v) and 0.01% thimerosal (w/v) (contains Hg, toxic) dissolved in nanopure 
water. 
Non–fat milk in TBS (TBSM): Nitrocellulose membrane was blocked with 5% (w/v) 
non–fat milk powder (Anchor, New Zealand) made in 1X TBS and was stored at 40C for 
up to 1 week. 
Ponceau S stain: The Ponceau S stain consisted of 0.01% Ponceau S (w/v) in 5% acetic 
acid. 
2.12.2  Antibodies 
Antibodies were stored at 40C and was added directly to the incubation solution. A table 
of antibodies and concentrations used is listed below. 
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Table 1: Antibodies and usage conditions. 
Agent Raised 
in 
Dilution Medium Incubation 
Time 
Supplier Conjugation Clonality 
GADD-
153 









Mouse 1: 2000 2.5% 
TBSM 





Mouse 1: 10,000 1% 
TBSM 





Mouse 1: 1000 2% 
TBSM 




2.12.3 Sample Preparation 
Cell lysate preparation: U937 suspension cell samples were transferred from wells to 1.5 
mL centrifuge tubes after an appropriate incubation time and were centrifuged at 15,000 
g for 5 minutes at 40C. The supernatant was discarded and the pellet was washed twice 
with cold PBS at 15,000 g for 5 minutes at 40C. The supernatant was discarded and pellet 
was resuspended in 200 μL of ice–cold lysis buffer containing protease inhibitor and were 
kept on ice for 2 minutes to ensure lysis. The samples were subjected to determine the 
protein concentration or were frozen at -200C for later use. 
2.12.4 SDS-polyacrylamide gel electrophoresis. 
A required volume of sample containing 100 ug of protein concentration was considered 
appropriate to be used for SDS–PAGE and western blot analysis. The required volume 
was aliquoted in to 1.5 mL centrifuge tube, was suspended into 400 μL of ice–cold 
Acetone and was centrifuged at 15,000 g for 10 minutes at 00C. The supernatant was 
discarded and tubes were left in fume hood for 15–30 minutes for remaining acetone to 
evaporate. The pellet was resuspended in 25 μL cracker buffer containing 2% β–
mercaptoethanol to final the protein concentration at 2–5 ug protein per μL. The samples 
were vortexed and heated in a heating block at 950C for 3 minutes to denature the protein. 
After denaturation, the samples were centrifuged at 15,000 g for 5 minutes at 40C. 5 μL of 
prestained molecular weight marker mix (Thermo Scientific, Lithuania) and 23 μL/well 
(Depending upon the required protein content) of samples were loaded into the wells. 
The samples were subjected to electrophoresis on the gradient polyacrylamide gel, (4–
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12% Bis–Tris gel, Invitrogen, Carslband, CA, USA) in 1X MOPS buffer. The gel was run at 
100 V and was later switched to 200 V after the dye front eluted from the wells. 
2.12.5 Immunoblotting 
After SDS–PAGE, the gel was transferred on to nitrocellulose membrane using a transblot 
turbo transfer pack (Bio–rad) preparing sandwich according to manufacturer’s 
instructions. The sandwich was enclosed into the cassette and was placed in Transblot 
turbo® transfer system (Bid–rad). The transfer system was set to 2.5 A, 25V and 10 
minutes to transfer proteins on to the nitrocellulose membrane. Once the transfer was 
completed the NC was rinsed with nanopure water and was stained with 0.01% Ponceau 
S stain for 1–2 minutes to examine the transfer efficiency. Pink protein bands were visible 
with Ponceau S stain. 
The following procedures were done on rocking platform mixer (Ratek Instruments, 
Australia and WiseMix, Wisd Laboratories Instrument). The membrane was given a quick 
rinse with water and was blocked in 5% non–fat milk in TBS (TBSM) for 1 hour with 
TBSM changing every 20 minutes. The membrane was washed with TBS for 25 minutes 
(TBS was changed every 5 minutes). The membrane was probed with GADD-153 (CHOP) 
monoclonal antibody (Santa Cruz Biotechnology Inc, USA) in 2.5% TBSM in 1: 50 dilutions 
and was incubated overnight at 40C. The membrane was given a quick wash with TBS and 
was washed again for 25 minutes (TBS was changed every 5 minutes) prior to secondary 
antibody incubation. The membrane was incubated with m-IgGқ BP-HRP secondary 
antibody (Sigma Aldrich, USA) in 1: 2000 dilution in 2.5% TBSM for 1 hour at room 
temperature. TBSM containing secondary antibody was discarded and membrane was 
washed with TBS for 25 minutes. After the wash, TBS was removed, the membrane was 
rinsed with nanopure water and kept in nanopure water for visualization. After 
visualization, the membrane was kept in nanopure water at 40C until re–probing. The 
membrane was stripped off the anti–GADD–153 antibodies before probing it for β–actin. 
The membrane was incubated in stripping buffer (2% SDS, 50 M tris, 400 μL β–
mercaptoethanol, pH 6.8 heated to 500C on a water bath) for 20–30 minutes. This was 
followed by 25 minutes TBS wash (TBS changed every 5 minute) and was directly 
incubated with β–actin primary antibody without blocking. 
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Visualization: The Chemiluminescence signal corresponding to the position of hydrogen 
peroxidase (HRP)–conjugated secondary antibody was detected by incubating 
membrane with Supersignal West Dura Chemiluminescence substrates 
(ThermoScientific, USA), which were mixed in ratio 1: 1. The images were recorded after 
2.5 minutes after the application of visualization of HRP substrate solution according to 
the manufacturer’s instructions. The images were obtained at high resolution, without 
filter or light using Syngene Chemigenius–2 bioimaging system (Logue, Cleary, Saveljeva, 
& Samali). Exposure time varied for different antibodies – from few seconds for β–actin 
(25 milliseconds-5 seconds) detection to 5–7 minutes (with EDR function ticked) or 20-
30 minutes (without ERD function ticked) in on Syngene Chemigenius-2 bioimaging 
system for GADD–153 (CHOP) detection (Clicking EDR). The images were analyzed for 
band intensity with GeneSnap (Syngene, USA) and ImageJ. 
2.13 Statistical analysis 
Statistical analysis was performed using GraphPad Prism Version 7.03 for Windows 10 
(GraphPad software, San Diego, California, USA), All experiments were performed in 
triplet and each data point was replicated at least thrice within an experiment. Unless 
stated, otherwise the results are displayed as Mean ± SEM of mean values from A) single 
experiment and B) Combined mean values from three separate experiments. Statistical 
significance was tested using one and two-factor analysis of variance (ANOVA), t-tests 
with 95% confidence intervals and linear regression. One factor ANOVA was followed by 
Dunnett’s post test, Bonferroni post test or Turkey’s multiple comparison test, where 
appropriate. A two-tailed t-test with 95% confidence interval was used when two sets of 
values were compared. The type of statistical test used in each experiment is indicated in 
the figure caption and the statistical significance is denoted by *, p < 0.05, **, p < 0.01 and 




3  RESULTS 
 
3.1  Effect of oxLDL toxicity on U937 cells. 
The research first examined oxLDL toxicity to U937 cells. U937 cells were treated with 
increasing concentrations of oxLDL (0.05 mg/mL–1.0 mg/mL) by incubation at 370C 
under standard incubation time of 24 hours. Cell viability was measured using PI-flow 
cytometry and MTT colorimetric assay. Cell morphology was assessed using an inverted 
light microscope (Figure 10A). Morphologically control cells (no oxLDL added) appeared 
round and circular which is a classical feature of U937 cells and resembling the 
monocytes. Cells treated with 0.05 mg/ mL, 0.1 mg/mL and 0.2 mg/mL oxLDL illustrated 
swelling or foamy appearance along with disruption of internal organelles. However, cells 
treated with 0.5 mg/mL or above a concentration of oxLDL indicated cell debris and 
distorted cell membranes, causing significant damage to their cell membranes and loss of 
cellular contents which are some common characteristic of necrotic cell death (as 
described in 1.3.2). Final oxLDL concentrations of 0.05, 0.1, 0.2, 0.5 and 1.0 mg/mL 
reduced U937 cell viability (PI Negative cells) by 92.35%, 88.02%, 55.64%, 16.11% and 
4.37% respectively (compared to control) (Figure 10B). Therefore, the LC50 
concentration obtained was 0.393 mg/mL, and the cell death percentage also elevated 
with increasing oxLDL concentrations (PI Positive cells) (Figure 10B). On the other hand, 
MTT assay showed results identical to that of PI-flow cytometry analysis. Cells treated 
with 0.05 and 0.1 mg/mL oxLDL yielded higher cell viability, 0.05 mg/mL oxLDL treated 
cells illustrated 116.12% viable cells and 0.1 mg/mL oxLDL treated cells resulted in 
109.58% viability (Figure 11). Cells treated with 0.2, 0.5 and 1.0 mg/mL oxLDL showed 
a rapid and significant decrease in cell viability. 0.2 mg/mL oxLDL treated samples 
depicted 69.58% cell viability compared to cell only control. However, 0.5 mg/mL and 1.0 
mg/mL oxLDL treated samples demonstrated a greater loss in viable cells which was 
about 17.49% and 3.18% compared to cell only control (Figure 11). 
45 
 
PI negative plus PI positive cells always added up to a value lower than 100% due to a 
number of cells that had completely lysed to became cellular debris demarcating them 
into a category of neither PI negative nor PI positive population. It is also important to 
note that the LC50 concentrations of oxLDL differed from batch–to–batch, but the toxicity 
remained somewhere between 0.1–0.5 mg/mL as determined using PI-Flow cytometry. 
However, in some rare situations the oxLDL toxicity was above 0.5 mg/mL. Later, it was 
also confirmed that the oxLDL toxicity varied within few weeks to few months which was 
shown by previous work (Sean ,2016).  
A) 
   
  
  
Cell only control 0.05 mg/mL 0.1 mg/mL 





Figure 10: Effect of oxLDL toxicity on U937 cell Viability by PI Flow cytometry 
U937 cells (0.5 X 106 cells/ml) were incubated at 370C in RPMI 1640 and 5% FBS with no 
phenol red and increasing concentrations of Cu-oxLDL for 24 hours in 24 well suspension 
culture plate. A) Cells were examined in situ using an inverted microscope (400X 
magnification) after 24 hours incubation with various oxLDL concentrations. Images 
were captured using a Leica C-Mount camera and processed using Leica Application suit 
software. B) Cell viability was determined using PI–Flow cytometry assay. Data are 
expressed as a percentage of total cell count in cell control only samples. Results are 
shown in mean ± SEM of technical replicates from a representative experiment. Statistical 
significance (two-way ANOVA, Sidak’s multiple comparison tests) is indicated by PI 
negative cell only control vs. PI-negative oxLDL treatments. Significance levels are shown 







Figure 11: Effect of oxLDL toxicity on U937 cell viability by MTT assay 
U937 cells (0.5 X 106 cells/mL) were incubated at 370C in RPMI and 5% FBS with no 
phenol red with increasing concentrations of oxLDL for 24 hours in 24 well suspension 
culture plates. Cell viability is determined using MTT assay. Cells were incubated with 
100 µL MTT reagent at 370 C for 2 hours. Purple crystals were formed and were dissolved 
in 1 mL 10% SDS. Absorbance was recorded using Agilent UV–Visible Spectrophotometer 
at 570 nm wavelength. Data are expressed as the percentage of living cells in control only 
samples. Results are shown in mean ± SEM of technical replicates from a representative 
experiment. Statistical significance (one-way ANOVA, Sidak’s multiple comparison tests) 
is represented by cell only control vs oxLDL treatments. Significance levels are indicated 




3.2  Effect of Thapsigargin (TG) on U937 cells  
Thapsigargin, a potent ER–stress inducer through its action as a non–competitive 
inhibitor of sarco/endoplasmic reticulum Ca2+ ATPase (SERCA) (Inesi & Sagara, 1994). 
The inhibitor elevates explicitly the intracellular Ca2+ influx and restricts the calcium 
pumping ability of cell into the endoplasmic reticulum. Previous work led by Izani (2015) 
focused on Thapsigargin-induced Ca2+ influx in the U937 cells. Thapsigargin is known to 
inhibit the fusion of autophagosome and lysosomes, which causes stress on endoplasmic 
reticulum causing cellular death (Ganley, Wong, Gammoh, & Jiang, 2011). Thapsigargin is 
also known to trigger apoptotic cell death by activating CHOP through ATF4 expression 
when the cell undergoes ER–stress (Hiroki Matsumoto et al., 2013). In the current 
experiment, we explored Thapsigargin-induced cytotoxicity in U937 cells. 
U937 cells were treated with the increasing concentrations of Thapsigargin (25 nM–100 
nM) and were incubated at 370C under standard incubation time of 24 hours. Cell viability 
was measured using PI–flow cytometry and MTT colorimetric assay. Cell morphology 
was assessed using an inverted light microscope. Morphologically, control cells (no TG 
added) appeared round and spherical which is a classical feature of U937 cells (Figure 
12A). Cells treated with 25 nM and illustrated swelling appearance and some amount of 
cell debris (Figure 12A). However, cells treated with 50 nM or above caused cell debris 
and distorted cell membranes, indicating significant damage to their cell membranes and 
loss of cellular contents which are some common characteristic of necrotic cell death 
(Figure 12A). Final TG concentrations of 25, 50, 75 and 100 nM reduced U937 cell 
viability (PI Negative cells) by 51%, 37%, 31%, and 30%, respectively (compared to 
control). Therefore, the LC50 concentration was obtained at 44.55 nM (Figure 12B). As 
with the oxLDL, sum of PI negative and PI positive cells was always lower than 100% due 
to a number of cells that had completely lysed to became cellular debris and were neither 
counted as PI negative nor PI positive population. The results obtained by MTT 
colorimetric assay followed a similar trend of decreasing cell viability with increasing 
concentrations of TG. It was observed that the final concentrations of 25, 50, 75 and 100 
nM lessened the viability by 78.60%, 66.50%, 56.49% and 53.30% respectively compared 
to the cell only control (Figure 13). The data obtained suggests that ER–stress inducer, 
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Figure 12: Effect of TG on U937 cell viability measured by PI-flow cytometry. 
U937 cells (0.5 X 106 cells/ml) were incubated at 370C in RPMI 1640 and 5% FBS with no 
phenol red with the increasing concentrations of TG for 24 hours in 24 well suspension 
culture plate. A) Cells were examined in situ using an inverted microscope (400X 
magnification) after 24 hours incubation with various TG concentrations. Images were 
captured using a Leica C-Mount camera and processed using Leica Application suit 
software. B) Cell viability was determined using PI–Flow cytometry assay. Data are 
expressed as a percentage of total cell count in cell control only samples. Results are 
shown in mean ± SEM of technical replicates from a representative experiment. Statistical 
significance (two-way ANOVA, Sidak’s multiple comparison tests) is indicated by PI 
negative cell only control vs. PI-negative TG treatments. Significance levels are shown as 







Figure 13: Effect of TG on U937 cell viability measured by MTT colorimetric assay. 
U937 cells (0.5 X 106 cells/mL) were incubated at 370C in RPMI 1640 and 5% FBS with 
no phenol red with increasing concentrations of TG for 24 hours in 24 well suspension 
culture plates. Cell viability is determined using MTT assay. Cells were incubated with 
100 µL MTT reagent at 370C for 2 hours. Purple crystals were formed and were dissolved 
in 1 mL 10% SDS. Absorbance was recorded using Shimadzu UV 1601PC UV-Visible 
Spectrophotometer at 570 nm wavelength. Data are expressed as the percentage of living 
cells in control only samples. Results are shown in mean ± SEM of technical replicates 
from a representative experiment. Cell only control vs represent statistical significance 
(one-way ANOVA, Sidak's multiple comparison tests). TG treatments. Significance levels 




3.3  Effect of Thapsigargin on Mitochondrial membrane 
potential (∆Ψm) in U937 cells. 
Changes in the mitochondrial membrane potential is directly linked to cell death. TG 
induced U937 cell death appeared more necrosis rather than apoptosis. The cell 
morphology indicated internal organelle structure degradation, cell swelling, disruption 
of nuclear membrane and rupture of the plasma membrane as seen in (Figure 15A). 25 
nM and 50 nM TG treated cells illustrated cell swelling compared to untreated cell only 
control (Figure 15A). The cells treated with 75 nM and 100 nM TG not only indicated cell 
swelling but degradation in internal organellar structures compared to healthy cell only 
control suggesting the evidence of necrotic cell death. Henceforth, it was necessary to 
observe whether these changes are linked the loss of mitochondrial membrane potential 
(∆Ψm).  
U937 cells were treated with increasing concentrations of Thapsigargin (25 nM–100 nM) 
and incubated at 370C for 24 hours. Sample preparation was done as described in 2.11.2 
and mitochondrial membrane potential was measured using TMRM dye and flow 
cytometry. CCCP (Carbonyl cyanide m-chlorophenyl hydrazone) was used as a positive 
control for loss of membrane potential for the experiment. It was observed that cell only 
control resulted in higher cell viability (Figure 14 and Figure 15) (76.37% compared to 
CCCP control cells) and low mitochondrial membrane potential (Figure 15). However, 
the changes in the mitochondrial membrane potential increased with the increasing TG 
concentration in the system. Cells treated with 25 nM TG showed an increase in 
membrane potential (Figure 15B) and decrease in the number of cells (60.78% 
compared to CCCP control) (Figure 16). Fluorescent intensity increased significantly 
with 50 nM and 75 nM (Figure 14 C and D) with decrease in the number of cells (48.09% 
and 47.43% compared to CCCP control cells) (Figure 16). Whereas, the fluorescent 
intensity decreased slightly when cells were treated with 100 nM TG (Figure 14E) along 
with a decrease in cell number (24.34% compared to CCCP treated control cells) (Figure 
15B). This increase in the fluorescent intensity and decrease in the cell number suggests 
heavy lysis.  
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Overall the results indicate the potential of TG induced cell death in U937 cells is 
mediated by the increase in ∆Ψm with increasing TG suggesting that the cell have lysed 
before the ∆Ψm can be measured. TG introduces Ca2+ efflux in the mitochondria, resulting 
in the opening of mitochondrial permeability transition pore leading to a loss in 
membrane potential. 
A) 
   
   
Cell only control 25 nM TG 
50 nM TG 75 nM TG 






U937 cells (0.5 × 106 cells/mL) were incubated at 370C in RPMI 1640 without phenol red 
and increasing concentration of TG for 24 hours in 24 well suspension culture plate. 
Treatments were incubated with 50 nM CCCP alone and 50 µM TMRM alone for 20 
minutes in the dark. Mitochondrial membrane potential was measured using FL–2 filter 
Figure 14: Mitochondrial membrane potential (∆Ψm) fluorescence intensity 
measurement by TMRM flow cytometry. 
A) Cell only control B) 25 nM TG C) 50 nM TG 
D) 75 nM TG E) 100 nM TG 
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by flow cytometer. Data is expressed as cell count vs mean cellular fluorescence. Each 
data expressed (A-E) is combined with CCCP control samples (black peak on the left side 






Figure 15: Effect of TG on mitochondrial membrane potential (∆Ψm) using TMRM 
staining. 
U937 cells (0.5 × 106 cells/mL) were incubated at 370C in RPMI 1640 without phenol red 
and increasing concentration of TG for 24 hours in 24 well suspension culture plate. 
Treatments were incubated with 50 nM CCCP alone and 50 µM TMRM alone for 20 
minutes in the dark. Mitochondrial membrane potential was measured using FL–2 filter 
by flow cytometer. Data is expressed as the mean cellular fluorescence intensity. A) Cells 
were examined in situ using an inverted microscope (400X magnification) after 24 hours 
incubation with various TG concentrations. Images were captured using a Leica C-Mount 
camera and processed using Leica Application suit software. B) Results are shown in 
mean ± SEM of technical replicates from a representative experiment. Statistical 
significance (one–way ANOVA, Dunnett’s multiple comparison tests) is indicated by CCCP 







Figure 16: Effect of TG on cell viability using TMRM staining. 
U937 cells (0.5 × 106 cells/mL) were incubated at 370C in RPMI 1640 without phenol red 
and increasing concentration of TG for 24 hours in 24 well suspension culture plate. 
Treatments were incubated with 50 nM CCCP alone and 50 µM TMRM alone for 20 
minutes in the dark. Mitochondrial membrane potential was measured using FL-2 filter 
by flow cytometer. Data is expressed as percentage of cell viability. Results are shown in 
mean ± SEM of technical replicates from a representative experiment. Statistical 
significance (one-way ANOVA, Dunnett’s multiple comparison tests) is indicated by CCCP 
vs treatments. Significant levels are shown (**), p < 0.01 and (***), p < 0.001. 
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3.4  Thapsigargin (TG)–induced CHOP activation in 
U937 cells. 
CHOP, a marker of ER–stress, is a 29 kDa protein is expressed when the cells undergo 
endoplasmic reticulum stress. A dose-dependent study to investigate CHOP activation by 
TG in U937 cells treated with increasing concentration of (TG) 10, 25, 50, 75 and 100 nM 
was carried out. 
After 24 hour incubation cells were extracted and lysed. The lysate was immunoblotted 
for CHOP protein activation with β-actin used as a loading control. CHOP expression was 
seen at 25 nM concentration (50.07% of control) (Figure 17B). The expression increased 
as the TG concentration increased. The CHOP activation was observed maximum at TG 
concentration at 50 nM concentration (92.63% of control). A significant decrease can be 
seen in the expression of TG at 75 nM concentration (46.55% of control) (Figure 17B). 
The expression again showed an elevation at a concentration of 100 nM TG (84.44% of 
control). Overall, the results suggest that U937 undergo ER stress when exposed to 










Figure 17: Thapsigargin-induced CHOP activation in U937 cells. 
U937 cells (0.5 × 106 cells/mL) were treated with increasing Thapsigargin concentration 
(25 nM-100 nM) at 370C for 24 hours in RPMI 1640 containing 5% FBS and phenol red. 
The cell lysate was assessed for CHOP expression by western blot. A) Results were 
normalised by β–Actin and displayed as mean ± SEM of technical replicate experiment. 
Data is expressed as the percentage of respective control (cell only control), and 
significance is indicated from this control. B) Quantitative densitometry of western blots 
shows CHOP expression with increasing levels of Thapsigargin using ImageJ.  






3.5  Effect of 7, 8–dihydroneopterin (7, 8–DNP) and 
Thapsigargin (TG) on CHOP activation in U937 cells. 
Another goal this research investigated was to determine whether macrophage 
synthesised antioxidant 7, 8–dihydroneopterin (7, 8-DNP) has any direct role in CHOP 
induction. Our research group previously investigated the role of 7,8–DNP on CD36 
expression, one of the primary scavenger receptor that uptake oxLDL. It has been found 
that 7,8–DNP downregulates CD36 expression levels in U937 cells and HMDM cells.  
Some preliminary experiments performed with 7,8–DNP and TG indicated LPS 
contamination due to which the CHOP activation was observed with negative control 7,8–
DNP and cell only control alone (Figure 18). Based the observation, it was known that 
LPS is considered to be one of the prime factors that activate CHOP without activating 
apoptotic ER–stress pathways (Nakayama et al., 2010). The experiment was performed 
on U937 cells (0.5 × 106 cells/mL) in phenol red free RPMI 1640 containing 5% FBS for 
24 hours at 370C. The cells were incubated with LC50 TG concentration of 44.55 nM alone 
(positive control), 7,8-DNP alone (negative control) and in combination with 7,8–DNP 
and TG. It was observed that the negative control and the cell only control activated CHOP 
on its own (38.89% and 42.80% compared to cell only control) (Figure 18). This problem 
was overcome by heat treatment on the materials that are often used to weigh up 7, 8–
DNP. The spatulas was preheated at 2200C for 2-3 hours prior weighing up 7, 8-DNP. With 
the preheat treatment the experiment was repeated to observe the effectiveness of pre-
heating the materials and weighing up 7, 8-DNP and can be observed in (Figure 19) 
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Figure 18: LPS is activating CHOP but not killing the cells. 
Continuing the current objective, U937 cells were incubated with no treatments (cell only 
control), 75 nM TG alone as a positive control, 200 µM 7,8–DNP as negative control and 
in combination with varying 7,8-DNP concentrations (50, 100, 150 and 200 µM) and 
75nM TG in RPMI 1640 with 5% FBS at 370C for 24 hours. The cells were extracted, lysed, 
and the lysate was immunoblotted for CHOP and β–actin was used as a loading control. 
The cell only control and 7, 8–DNP (negative control) has no CHOP activation (Figure 
19B). 75 nM TG (positive control) expressed CHOP (121.95% of cell-only control). 50 µM 
7,8-DNP and TG treated sample resulted in 71.91% expression compared to cell only 
control. The significant decrease in CHOP expression can be observed as the 7,8-DNP 
concentration in the cellular system increases. When the cells were incubated with TG 
CHOP 
Β – Actin 
TG (nM) 
7, 8–DNP (µM)  
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and 100 µM 7,8-DNP the level of CHOP expression decreased gradually from 71.91% to 
68.87% compared to cell only control. A very slight fall in CHOP expression (68.64% 
compared to cell control) can be seen when the cells were treated with TG and 150 µM. 
However, when the cells were treated with TG and highest concentration of 200 µM 7,8-
DNP, a substantial decrease in CHOP expression, 57.67% compared to cell only control 
was observed, apparently suggesting that 7,8-DNP is effective in downregulating CHOP 
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Figure 19: Effect of 7, 8-DNP on TG-induced CHOP activation in U937 cells. 
U937 cells (0.5 × 106 cells/mL) were incubated with 200 µM 7, 8-DNP, 75 nM TG alone 
and in combination with 75 nM TG and varying 7, 8-DNP concentrations (50, 100, 150 
and 200 µM) for 24 hours at 370C in RPMI 1640 without phenol red and containing 5% 
FBS. The cell lysate was assessed for CHOP expression using western blot. A) Results 
were normalised by β-Actin and displayed as mean ± SEM of technical replicates from a 
representative experiment. Data is expressed as the percentage of respective control (cell 
only control). Statistical significance (one-way ANOVA, Dunnett’s multiple comparison 
tests) is indicated by cell only control vs treatments. Significant levels are shown (*), p < 
0.05 and (**), p < 0.01. B) Quantitative densitometry of western blots showed CHOP 
expression with increasing concentrations of TG and fixed 7, 8-DNP concentration.  
  
CHOP 





3.6  Dose-dependent oxLDL–induced CHOP activation 
in U937 cells. 
With the confirmation of TG inducing CHOP expression in U937 cells, the primary aim of 
the project was to observe whether oxLDL is exhibiting CHOP to initiate cell death 
response pathways. 
U937 cells were incubated with varying concentrations of oxLDL; 0.1, 0.2, 0.3, 0.4, 0.5 
mg/mL and 100 nM (used as positive control) respectively for 24 hours. The cells were 
extracted, lysed and subjected to immunoblotting for CHOP expression with β-actin as a 
loading control. TG elevated CHOP expression (74.58% of control) while cell only control, 
0.1 and 0.2 mg/mL oxLDL treated samples did not activate CHOP. In contrast, CHOP 
expression was first observed in 0.3 mg/mL oxLDL treated samples (37.31% of control). 
The CHOP expression initially increased with the 0.4 mg/mL oxLDL treated sample 
(59.41% of control) and was maximum with 0.5 mg/mL oxLDL treated sample (128.5% 
of control).  
We also found out that different batch of oxLDL may or may not trigger CHOP activation 
in U937 cells. In one such batch, we observed CHOP activation through TG only positive 
control whereas no activation was observed with higher treated oxLDL samples. 
However, the results mentioned above confirm that U937 cells do exhibit CHOP and 










Figure 20: Dose–dependent effect of oxLDL on CHOP activation in U937 cells. 
U937 cells (0.5 × 106 cells/mL) were treated with TG only (100 nM) and increasing oxLDL 
concentration (0.1 mg/mL–0.5 mg/mL) at 370C for 24 hours in RPMI 1640 containing 5% 
FBS without phenol red. The cell lysate was assessed for CHOP expression by western 
blot. A) Results were normalised with β-Actin and displayed as mean ± SEM of technical 
replicates of the representative experiment. Data are expressed as the percentage of 
respective control (cell only control). Statistical significance (one-way ANOVA, Dunnett’s 






multiple comparison tests) is indicated by cell only vs treatments. Significant levels are 
shown (*), p < 0.05 and (***), p < 0.001. B) Quantitative densitometry of western blots 




3.7  Time-dependent oxLDL induced CHOP activation in 
U937 cells. 
Based on the results obtained by dose dependent treatment of oxLDL (section 3.6), a 
time dependent study was followed as to see at what time point can CHOP activation be 
seen with a fixed oxLDL concentration.  
U937 cells were incubated with 0.4 mg/mL oxLDL for 0, 3, 6, 12 and 24 hours 
respectively, followed by the incubation of 100 nM TG alone for 12 and 24 hours as a 
positive control for the experiments. At each time point mentioned the cells were 
extracted, lysed. The lysate was immunoblotted for CHOP activation with β-actin as a 
loading control. 0.4 mg/mL oxLDL did not show any CHOP activation at 0 hour time points 
(Figure 21B). A CHOP activation band can be observed at 3 hour (30.70% of control) 
with the increased expression at 6 hour 12 hour which nearly doubled at 24 hour time 
point (33.51%, 42.01% and 100.46% of control) (Figure 21B). In correspondence to 
oxLDL treatment, positive control 100 nM TG also exhibited CHOP expression at 12 hour 
and 24 hour time points (45.75% and 104.16% of control) (Figure 21B). It can also be 
observed that nearly 50% CHOP is activated at 12 hour time point with the expression 
doubling at 24 hour time point (Figure 21B). It is also important to note that the β-actin 
bands seen in this particular experiment gave the similar results when performed in 
technical replicates. The intensity of actin bands deteorated with the time in oxLDL 
treated and TG treated control samples. The intensity of actin bands reduced at 12H and 
24H oxLDL treatments whereas it was barely visible in 12H and 24H TG controls. We do 
not know the reason as to why there was reduction in actin band intensity, especially in 
12H and 24H TG controls (Figure 21B). There are some possibilities we suspect; might 
be due to TG effecting β-actin or high concentrations of TG which is killing the cells in 
higher amount or insufficient protein loading or some error in BCA protein determination 
assay. 
The following result obtained suggests that a minimum of 3 hours is required by U937 
cells to trigger CHOP activation by 0.4 mg/mL oxLDL to further initiate cell death 












Figure 21: Time dependent activation effect of oxLDL on CHOP activation in U937 
cells. 
U937 cells (0.5 × 106 cells/mL) were treated with 0.4 mg/mL oxLDL and 100 nM TG for 
varying time points at 370C for 24 hours in RPMI 1640 containing 5% FBS without phenol 
red. The cell lysate was assessed for CHOP expression via western blot. A) Results were 
normalised by β-Actin and displayed as mean ± SEM of technical replicates of 
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representative experiments. Data are expressed as the percentage of individual control 
(cell only control), and significance is indicated from this control. Statistical significance 
(one-way ANOVA, Dunnett’s multiple comparison tests) is indicated by cell only control 
vs treatments. Significant levels are shown (*), p < 0.05. B) Quantitative densitometry of 




3.8  Effect of ACAT inhibitor (Sandoz 580–35) and 
oxLDL on cell viability. 
U937 cells were incubated with 0.1 mg/mL and 0.2 mg/mL oxLDL alone, 10 µg/mL ACAT 
inhibitor, combination with 0.1 mg/mL oxLDL and 10 ug/mL ACAT inhibitor and 0.2 
mg/mL and 10 µg/mL ACAT inhibitor for 24 hours at 370C. Cell viability was measured 
using PI flow cytometry and morphology was assessed with inverted light microscope. 
0.1 mg/mL oxLDL control had minimum or no effect on the U937 cells as compared to 0.2 
mg/mL oxLDL control indicating 89% and 68% viable cells respectively (Figure 22). The 
oxLDL concentration used is below the known lethal concentration. 10 µg/mL ACAT 
inhibitor control alone prooves to be toxic to U937 cells resulting in only 35.5% viable 
cells. However, the combination treatment of 0.1 mg/mL oxLDL and 10 µg/mL accounts 
for 92% cell viability. The combine treated group elevated the cell viability by almost 2% 
and 57% compared to 0.1 mg/mL oxLDL control and ACAT inhibitor alone treated cells. 
Combine treatment of 0.2 mg/mL oxLDL and 10 µg/mL ACAT also raised the cell vaibility 
when compared with 0.2 mg/mL oxLDL and 10 µg/mL ACAT inhibitor alone control. In 
0.2 mg/mL oxLDL and ACAT inhibitor treated cells showed 25% and 58% increase in 
vaibility respectively when compared to 0.2 mg/mL oxLDL and 10 µg/mL ACAT inhibitor 
alone (Figure 22). 
MTT contrasting results compared to the viability results obtained via PI-flow cytometry. 
Untreated samples, 0.1 mg/mL and 0.2 mg/mL oxLDL treated samples showed a increase 
in viable cells. Cell only control resulted in 100% cell viability whereas 0.1 mg/mL and 
0.2 mg/mL oxLDL treated samples yielded 106.89% and 112.79% cell viability 
respectively, compared to cell only control (Figure 23). The oxLDL concentration used is 
below the known lethal concentration. These results were in contrast to PI data which 
illustrated a significant decrease in cell viability (PI negative cells) when the cells were 
treated with 0.1 and 0.2 mg/mL oxLDL. However, a slight drop in cell viability was 
observed when the cells were treated with 10 µg/mL S 58-035 resulting in 102.05% cell 
viability to cell only control which is almost 30-fold higher than that of PI-flow cytometer 
data. Nevertheless, the results are quite similar to PI data (Figure 22) when the cells 
were incubated in combination with oxLDL and ACAT inhibitor. 0.1 mg/mL, 0.2 mg/mL 
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oxLDL and 10 µg/mL ACAT resulted in 134.70% and 135.18% cell viability compared to 
cell only control suggesting that ACAT inhibitor is having a protective effect on U937 cell 






Figure 22: Effect of ACAT inhibitor (Sandoz 580-35) and oxLDL on cell viability 
measured by PI-flow cytometry. 
U937 cells (0.5 X 106 cells/ml) were incubated at 370C in RPMI 1640 and 5% FBS without 
phenol red with 10 µg/mL of ACAT inhibitor (Sandoz 58–035) and 0.1 mg/mL and 0.2 
mg/mL oxLDL for 24 hours in 24 well suspension culture plate. Cell viability was 
determined using PI–Flow cytometry assay. Data are expressed as a percentage of total 
cell count in cell control only samples. Results are shown in mean ± SEM of technical 
replicates from a representative experiment. Statistical significance (two-way ANOVA, 
Dunnett's multiple comparison tests) is indicated by PI negative cell only control vs. PI-
negative ACAT inhibitor treatments. Significance levels are shown as (*), p < 0.05, (**),p 





Figure 23: Effect of ACAT inhibitor S 58-035 and oxLDL on U937 cell viability by 
MTT colorimetric assay. 
U937 cells (0.5 X 106 cells/mL) were incubated at 370C in RPMI 1640 and 5% FBS with 
no phenol red with 0.1 mg/mL, 0.2 mg/mL oxLDL and 10 µg/mL ACAT inhibitor S 58-035 
alone and in combination with oxLDL and S 58-035 for 24 hours in 24 well suspension 
culture plates. Cell viability is determined using MTT assay. Cells were incubated with 50 
µL MTT reagent at 370C for 2 hours. Purple crystals were formed and were dissolved in 
500 µL 10% SDS. Absorbance was recorded using Shimadzu UV 1601PC UV-Visible 
Spectrophotometer at 570 nm wavelength. Data are expressed as the percentage of living 
cells in control only samples. Results are shown in mean ± SEM of technical replicates 
from a representative experiment. Cell only control vs TG treatments represent statistical 
significance (one-way ANOVA, Sidak's multiple comparison tests). Significance levels are 
indicated as (*) p < 0.05, (**) p < 0.01 and (***) p < 0.001. 
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3.9  Effect of ACAT inhibitor (Sandoz 580-35) on U937 
cells. 
The data presented in 3.8 indicated that 10 ug/mL ACAT alone was toxic to U937 cells. 
Therefore, it was important to analyse the cytotoxicity of ACAT inhibitor on U937 cells. 
U937 cells were treated with increasing concentrations of ACAT inhibitor (Sandoz 580-
35) (10 µg/mL-100 µg/mL) and were incubated at 370C for 24 hours. Cell viability was 
measured by PI flow cytometry, and cell morphology was assessed by an inverted light 
microscope. Increasing concentrations of ACAT inhibitor 10, 25, 50, 75 and 100 µg/mL 
reduced the cell viability (PI Negative cells) and increased dead cell population (PI 
Positive cells). As the ACAT concentration increased, the cell viability (PI Negative cells) 
decreased to 19%, 17%, 26%, 56% and 80% respectively. The LC50 of ACAT inhibitor was 
determined using linear regression and was calculated to be 60.215 µg/mL. The sum of 
PI Positive and PI Negative cells was always lower than 100% due to the number of cells 
that completely lysed to became the part of cellular debris which was considered neither 
of PI negative nor PI positive cell population.  
On the other hand, MTT assay yielded 100% cell viability with 10 µg/mL of ACAT 
inhibitor compared to cell only control. The cell viability decreased very slightly resulting 
in 94.18% viable cells compared to cell only control when the cells were incubated with 
25 µg/mL of ACAT inhibitor which is 14.46% higher compared to the what observed in 
PI. The viability decreased significantly when the concentration of ACAT inhibitor 
increased. 50 µg/mL concentration reduced the cell viability to 87.64% compared to cell 
only control. The cell viability suddenly dropped to 69.38% followed by 53.18% when 
the cells were treated with 75 µg/mL and highest concentration of 100 µg/mL of ACAT 
inhibitor. This sudden drop in cell viability with 75 µg/mL and 100 µg/mL can also be 
seen when analysed by PI flow cytometry.  
Overall the data obtained suggest that ACAT inhibitor is toxic to U937 cells when given in 
higher concentrations above 25 µg/mL. However, concentrations ranging between 1-10 





Figure 24: Effect of ACAT inhibitor on U937 cell viability by Flow cytometry 
U937 cells (0.5 X 106 cells/ml) were incubated at 370C in RPMI 1640 with 5% FBS without 
phenol red and increasing concentrations of ACAT inhibitor for 24 hours in 24 well 
suspension culture plate. Cell viability was determined using PI-Flow cytometry assay. 
Data are expressed as a percentage of total cell count in cell control only samples. Results 
are shown in mean ± SEM of technical replicates from a representative experiment. 
Statistical significance (two-way ANOVA, Sidak’s multiple comparison tests) is indicated 
by PI negative cell only control vs. PI-negative ACAT inhibitor treatments. Significance 





Figure 25: Effect of ACAT Inhibitor (S 58-035) on U937 cells by MTT colorimetric 
assay. 
U937 cells (0.5 X 106 cells/mL) were incubated at 370C in RPMI 1640 and 5% FBS without 
phenol red and increasing concentrations of ACAT Inhibitor (S 58-035) for 24 hours in 
24 well suspension culture plates. Cell viability is determined using MTT assay. Cells were 
incubated with 50 µL MTT reagent at 370C for 2 hours. Purple crystals were formed and 
were dissolved in 500 µL 10% SDS. Absorbance was recorded using Shimadzu UV 1601PC 
UV–Visible Spectrophotometer at 570 nm wavelength. Data are expressed as the 
percentage of living cells in control only samples. Results are shown in mean ± SEM of 
technical replicates from a representative experiment. Cell only control vs represent 
statistical significance (one-way ANOVA, Sidak's multiple comparison tests). TG 




3.10  Effect of oxLDL on human monocytes. 
Human monocytes react to oxLDL in a similar way to U937 cells. Preliminary experiments 
were performed on human monocytes treated with increasing concentrations of oxLDL 
(0.2, 0.4, 0.6, 0.8, 1.0 and 1.2 mg/mL) in phenol red free RPMI 1640 containing 10% 
human serum at 370C for 24 hours. Cell viability was measured using PI flow cytometry 
and MTT colorimetric assay. Cells treated with 0.2 mg/mL oxLDL showed a higher 
percentage of cell viability (PI negative cells) resulting for 119.23% of cell-only control 
which can be seen same when assayed with MTT assay (117.99% of cell-only control). 
Cells treated with 0.4 mg/mL oxLDL reduced the cell viability to 85.20% compared to cell 
only control and MTT resulted in 107.69% viable cells compared to cell only control. Cells 
treated with 0.6 mg/mL oxLDL deduced the viability by 50.05% compared to cell only 
control whereas this sudden drop in cell viability (PI negative cells) was not observed 
with MTT colorimetric assay (101.66% of control). Cells treated with 0.8, 1.0 and 1.2 
mg/mL oxLDL showed the increase in viability (93.60% for 0.8 mg/mL compared to 
control) (PI negative cells) and again decreased as the concentration of oxLDL increased; 
75.83% for 1.0 mg/mL oxLDL compared to control and 50.85% for 1.2 mg/mL oxLDL 
compared to control (PI Negative cells). 
However, MTT did not follow the same trend in viability as compared to PI flow 
cytometry. The percentage of viable cells diminished with increasing concentration of 
oxLDL. Cells treated with 0.8 mg/mL oxLDL gave 99.66% viable cells compared to 
control;1.0 mg/mL oxLDL gave 88.85% viable cells and 1.2 mg/mL oxLDL gave 84.50% 
viability compared to cell only control. However, it was not possible to determine the LC50 
concentration of oxLDL for human monocytes due to variation in cell viability and 




Figure 26: Effect of oxLDL on Human Monocytes using PI Flow cytometry. 
Human monocytes (1 X 106 cells/ml) were incubated at 370C in RPMI 1640 and 10% 
human serum with no phenol red and increasing concentrations of oxLDL for 24 hours in 
24 well suspension culture plate. Cell viability was determined using PI-Flow cytometry 
assay. Data are expressed as a percentage of average cell count in cell control only 
samples. Results are shown in mean ± SEM of technical replicates from a representative 
experiment. Statistical significance (two-way ANOVA, Sidak’s multiple comparison tests) 
is indicated by PI negative cell only control vs. PI-negative TG treatments. Significance 






Figure 27: Effect of oxLDL on Human monocytes by MTT colorimetric assay. 
Human monocytes (1 X 106 cells/mL) were incubated at 370C in RPMI 1640 and 5% FBS 
with no phenol red and increasing concentrations of oxLDL for 24 hours in 24 well 
suspension culture plates. Cell viability is determined using MTT assay. Cells were 
incubated with 50 µL MTT reagent at 370 C for 2 hours. Purple crystals were formed and 
were dissolved in 500 µL 10% SDS. Absorbance was recorded using Shimadzu UV 1601PC 
UV-Visible Spectrophotometer at 570 nm wavelength. Data are expressed as the 
percentage of living cells in control only samples. Results are shown in mean ± SEM of 
technical replicates from a representative experiment. Statistical significance (one-way 
ANOVA, Sidak’s multiple comparison tests) is represented by cell only control vs oxLDL 




3.11 Effect of Thapsigargin on human monocytes. 
Preliminary experiments were performed on human monocytes (1 × 106 cells/mL) 
treated with increasing concentrations of TG (50, 100, 150, 200, 250, 300 and 350 nM) 
incubated in phenol red free RPMI 1640 with 10% human serum at 370C for 24 hours. 
Cell viability was measured using PI flow cytometry and MTT colorimetric assay. Cells 
treated with 50 nM TG resulted in 99.89% viable (PI negative) as compared to a cell 
control, whereas MTT showed 105.32% viable cells as compared to PI flow cytometry. 
The viability decreased with increase in TG concentration 100 nM treated cells depicted 
96.53% cell viability; 150 nM treated cells resulted in 87.01% cell viability; 200 nM 
treated cells gave 64.53% cell viability; 250 nM TG treated cells resulted in slight rise in 
viability accounting for 79.31%; 300 nM TG treated sample resulted in viability almost 
equal to that of 200 nM TG treated sample giving 60.83% viable cells and highest 
treatment of 350 nM TG resulted in the least percentage of viable cells illustrating 58.05% 
viable cells compared to cell only control. 
This suggests that TG is toxic to human monocytes. It can also be seen that monocyte’s 
response to TG is not as sensitive as that observed in U937 cells .However, due to 




Figure 28: Effect of TG on Human monocytes by PI flow cytometry. 
Human monocytes (1 X 106 cells/ml) were incubated at 370C in RPMI 1640 containing 
10% human serum without phenol red and increasing concentrations of TG for 24 hours 
in 24 well suspension culture plate. Cell viability was determined using PI–Flow 
cytometry assay. Data are expressed as a percentage of average cell count in cell only 
control samples. Results are shown in mean ± SEM of technical replicates from a 
representative experiment. Statistical significance (two-way ANOVA, Sidak’s multiple 
comparison tests) is indicated by PI negative cell only control vs. PI-negative TG 






Figure 29: Effect of TG on Human monocytes by MTT colorimetric assay. 
Human monocytes (1 X 106 cells/mL) were incubated at 370C in RPMI 1640 containing 
10% human serum without phenol red and increasing concentrations of TG for 24 hours 
in 24 well suspension culture plates. Cell viability is determined using MTT assay. Cells 
were incubated with 50 µL MTT reagent at 370C for 2 hours. Purple crystals were formed 
and were dissolved in 500 µL 10% SDS. Absorbance was recorded using Agilent UV–
Visible Spectrophotometer at 570 nm wavelength. Data are expressed as the percentage 
of living cells in control only samples. Results are shown in mean ± SEM of triplicates from 
a representative experiment. Statistical significance (one-way ANOVA, Sidak’s multiple 
comparison tests) is represented by cell only control vs oxLDL treatments. Significance 







4.1  General discussion, conclusion and future work. 
This research explores the critical role of oxidized LDL in endoplasmic reticulum stress-
induced cell death by the activation of one of the critical ER stress markers CHOP. The 
research also examined the potential of the macrophage antioxidant 7, 8-DNP to 
downregulate CHOP expression induced by oxLDL and determining its ability in the 
prevention of macrophage cell death processes in later stages of atherosclerosis 
progression. 
4.1.1 Oxidized low density proteins induced cell death. 
OxLDL is believed to be the primary contributor to macrophage cell death. LDL gets 
modified into oxidized LDL by the ROS such as H2O2, HOCl and NO that are present in the 
intima of the artery and are readily taken up by the macrophages converting them into 
the cholesterol loaden foam cells which is the hallmark of atherosclerosis. Excess of free 
radicals that are derived from oxygen, nitrogen and other chemical substances in the 
body causes lipids and proteins to be oxidized through the terminal process of oxidative 
stress. Oxidative stress leads to crucial events like cell death and proliferation as 
atherosclerosis progresses. It is quite intriguing that mild oxidation can trigger cellular 
stress and initiate apoptosis, however, severe oxidative stress can trigger cell death, and 
intense stress may result in the cells to undergo necrotic death (Circu & Aw, 2010).  
In the current research, we have utilized CuCl2 as a mediator to heavily oxidize the native 
LDL for prolonged periods (more than 24 hours) (Steven P Gieseg, Crone, & Amit, 2009). 
This heavily oxidized Cu-oxLDL was used to study the mechanism and kinetics of oxLDL 
(precisely Cu–oxLDL). Alternatively, LDL can also be oxidized by acetylation (acLDL), 
aggregation (agLDL), minimal oxidation (mLDL) or be oxidized using hypochlorite 
(HOCl–oxLDL) depending upon the type and research to be carried out. Evidences 
84 
 
suggests that macrophage undergo foam cell formation when treated with agLDL, but it 
has also been seen that apoptosis is suppressed by downregulating caspase-1 and -3 with 
upregulation of γ-interferon at the same time (Kubo et al., 1997). Apoptotic cell death 
caused by agLDL is p53 dependent process (Kinscherf et al., 1998) and hence it is 
involved in events such as cell loss, the formation of a lipid core and other thrombotic 
events. It has also been evidenced that short oxLDL treatment (4-6 hours) with 0.1 
mg/mL Cu-oxLDL leads to cell survival, enhanced response to GM-CSF and DNA synthesis 
(Hamilton et al., 1999; C.-Y. Han & Pak, 1999). We observed the similar results with cell 
survival when the U937 cells were treated with 0.1 mg/mL Cu-oxLDL for 24 hours. One 
of the critical evidence also suggested that exposing cells to 0.1 mg/mL mLDL induced 
cell proliferation and macrophage activation, however, highly oxidized LDL at same 
concentration induced cell death. Whereas, 0.2 mg/mL Cu-oxLDL resulted in cell death 
regardless of the oxidation degree of oxLDL (C.-Y. Han & Pak, 1999). We confirmed the 
similar results with highly oxidized oxLDL (Cu-oxLDL) where we observed the reduction 
in cell viability when the cells were incubated with 0.2 mg/mL Cu-oxLDL and higher 
concentrations (Figure 10 and Figure 11).  
Preliminary experiments with Cu-oxLDL on human monocytes suggested that Cu-oxLDL 
is toxic to monocytes in same ways as that of U937 cells. However, we could not 
determine the LC50 for monocytes due to an insufficient concentration of oxLDL in the 
system (Figure 26 and Figure 27). We assume that monocytes are not as sensitive as 
that of U937 cells irrespective of same cell concentration. However, the cytotoxicity is 
dependent on the toxic nature of oxLDL.  
Previous studies have shown that oxLDL either induce apoptotic or necrotic cell death 
depending upon the type of cells treated. When treated with increasing concentrations of 
Cu–oxLDL, cells undergo oxidative stress as it was sufficient to block caspase-3 activation 
and suppress apoptotic process further activating necrosis in U937 cells (Baird et al., 
2004). However, THP-1 cells underwent apoptosis through caspase-3 activation (Baird 
et al., 2004). Our current study was initiated by treating U937 cells with varying 
concentrations of Cu-oxLDL and we found out that U937 cells are highly sensitive as the 
concentration increases. As a result, the cells undergo cell death by necrosis when 
assessed by inverted light microscope (Figure 10A). The cells showed swelling followed 
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by the degradation of internal organelle structure, disruption of nuclear and plasma 
membrane. We observed that cell only control appeared round which is classical feature 
of U937 cells. Although, cells treated with 0.1 mg/ mL and 0.2 mg/mL oxLDL illustrated 
swelling or foamy appearance. In contrast cells treated with higher concentration of Cu-
oxLDL (concentrations above 0.3 mg/mL) illustrated cell debris with distorted cell 
membranes, resulting a significant damage to their cell membranes and loss of cellular 
contents which are some common characteristic of necrotic cell death (Syntichaki & 
Tavernarakis, 2003). The decrease in cell viability was observed with elevating oxLDL 
concentrations (PI Negative cells) (Figure 10B) with increase in the percentage of dead 
cells (PI Positive cells) (Figure 10B) when assessed by PI flow cytometry. The research 
also utilized MTT colorimetric assay as a measure to determine cell viability. MTT is a 
soluble tetrazolium salt which accepts electrons from oxidized substrates such as NADH 
and NADPH by the viable cells converting tetrazolium into an insoluble formazan; 
transforming yellow tetrazolium salts into blue colored formazan crystals that can be 
spectrophotometrically determined. Hence the viable cells produced more amount of 
insoluble formazan as compared to dead cells. In case of oxLDL, the viability decreased as 
the oxLDL concentration increased (Figure 11) and illustrated the similar trend in 
decrease as seen PI Flow cytometry. Overall these findings suggest that oxLDL induced 
cell death is cell’s response to oxLDL which depends on the degree of oxidation, 
aggregation status, the concentration of oxLDL and exposure time.  
4.1.2 OxLDL induces Endoplasmic reticulum stress pathway to 
initiate cell death by CHOP pathway. 
The next objective of the research was to investigate the potential role of oxLDL in 
triggering ER stress and CHOP-induced cell death in U937 cells. Scavenger receptors are 
responsible for the uptake of oxLDL. Among these SR-A, SR-B (CD36), LOX-1 and TLR4 
are the prominent receptors that gather oxLDL and results in the foam cell formation 
(Levitan et al., 2010). The increasing concentration of oxLDL in the cells activates various 
mechanism such as oxidative stress, calcium homeostasis imbalance and inflammation 
that dysfunctions ER leading to the misfolding of proteins and activating UPR to reduce 
the load of misfolded proteins (Hotamisligil, 2010). There are plenty of evidences that 
suggests that scavenger receptors and oxLDL are involved in triggering ER stress through 
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various ER proteins and CHOP induction (Figure 30). It has been previously shown that 
both minimally modified oxLDL (mm-oxLDL) and oxLDL can activate ER-stress during 
foam cell formation. Shutong Yao et al. (2012) shown that mm-LDL increased the 
expressions of ER membrane proteins p-IRE1, XBP1 and GRP78 in dose-dependent 
manner (Yao et al., 2012). The study also suggested that TLR4 which is among the major 
transmembrane receptor responsible for foam cell formation, not only alleviated FC 
trafficking in ER by mm-oxLDL but it also inhibited ER-stress response by reducing the 
nuclear translocation of ATF6, IRE1 and XBP1 and GRP78 downregulation. Notably, when 
TLR4 was transfected by siRNA, it upregulated the expression of p-IRE1, GRP78 and ATF6 
induced by mm-LDL suggesting the crucial role played by TLR4 in mediating mm-LDL 
induced macrophage ER-stress (Yao et al., 2012). Research led by Hua et al. (2010), 
concluded that ER–stressor Tunicamycin elevates CD36 protein levels in human 
macrophages suggesting the potential role of ER–stress in the expression of scavenger 
receptors during atherosclerosis progression (Hua, Kandadi, Zhu, Ren, & Sreejayan, 
2010). 
Another important research carried by Shutong Yao et. al. not only showed that oxLDL 
upregulates CHOP expression but also illustrated that ATF6 (discussed in 1.2.2.3) which 
regulates CHOP expression, was activated by oxLDL in time and dose-dependent manner. 
This was followed by the upregulation of oxLDL induced CHOP activation, macrophage 
cell death by apoptosis when ATF6 was knocked out by siRNA transfection indicating the 
role of ATF6 in ER–stress pathway. This finding showed that oxLDL induced CHOP 
upregulation and apoptotic cell death by ATF6-siRNA transfection was only partial effect. 
Overall the results suggested that ATF6 play a crucial role in mediating oxLDL induced 
cholesterol accumulation and macrophage cell death by upregulating CHOP expression 
(Yao et al., 2013).  
The primary motive of our research project was to determine whether Cu–oxLDL activate 
CHOP driven cell death mechanism in U937 cells. A significant finding mentioned above 
did explain the potential role played by oxLDL in CHOP activation through scavenger 
receptors and ER-membrane proteins. We investigated CHOP activation using a potent 
ER–stress inducer Thapsigargin (TG) which is a SERCA inhibitor. It was seen that CHOP 
was upregulated in a dose-dependent manner (Figure 17). Not only it showed that U937 
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express TG induced CHOP upregulation, but it also showed that U937 cells undergo 
necrotic cell death rather than apoptotic cell death. This was evident by TMRM staining 
by flow cytometry. TMRM dye measures the change in mitochondrial membrane 
potential. It was observed that the TMRM fluorescence increased with increasing TG 
concentration with the reduction in cell number. This suggests that the cell experienced 
heavy lysis right before the membrane potential was measured.  
We know that oxLDL is a main contributing factor resulting in foam cell formation and 
macrophage cell death. The oxidized form of LDL is known to trigger cell death one of the 
prominent and well-studied pathways of ER-stress and CHOP-mediated cell death in a 
variety of cell lines (see APPENDIX). Here we investigated the potential role of oxLDL in 
mediating cell death in U937 cells through activation of CHOP which is among the leading 
markers of ER-stress. The results we obtained suggested that oxLDL initiated CHOP-
mediated cell death is dependent on the concentration of oxLDL and time it gets activated. 
We observed that oxLDL triggered CHOP activation at 0.3 mg/mL oxLDL and the 
expression upregulated as the concentration of oxLDL in the cells increased. At the 
highest concentration of 0.5 mg/mL CHOP expression was observed to be maximum 
killing almost all cells. The time-dependent CHOP expression was also observed which 
suggested that oxLDL-induced CHOP activation was first observed at 3-hour time point 
when the cells were treated with 0.4 mg/mL oxLDL. The expression appeared maximum 
at 12 and 24-hour time point suggesting that 3-hour time is the initiation point for oxLDL 
induced CHOP mediated cell death in U937 cells. We also observed TG (positive control) 
activating CHOP at 12 hour and maximum expression was followed by 24 hours acting as 
a control for our time-course experiment. However, it is imperative to note that we 
observed CHOP activation only with one batch of oxLDL prepared. We suppose that 
oxLDL induced CHOP activation varies from batch-to-batch of oxLDL prepared as we 
know that oxLDL toxicity also changes with new batch prepared. However, we do not 
know the reason behind different batches of oxLDL activating CHOP expression in U937 
cells.  
NOX activation is among the critical factors that are responsible for CHOP mediated cell 
death. There are several mechanisms by which NOX activates CHOP-induced cell death in 
cells. One of the critical mechanism reported by Li et al., (2010) suggested that NOX plays 
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a fundamental role in formation of excessive ROS by which the cell undergoes oxidative 
stress and activates calcium signalling pathways by triggering CHOP through ER-oxidase 
1α (ERO1α), initiating the calcium release through a calcium channel, IP3R (Figure 30). 
This calcium channel then triggers cytoplasmic calcium to activate calcium-sensing 
enzyme CaMKII which causes the activation of downstream apoptotic pathways leading 
to Fas-mediated apoptosis (Figure 30). Hence, it would be beneficial to explore the role 
of NOX in Cu-oxLDL induced CHOP mediated cell death in U937 cells and human 
monocytes/macrophages. 
 
Figure 30: ER - stress-induced apoptotic pathways taken from (Scull & Tabas, 2011) 
Another important mechanism by which CHOP facilitates cell death is through ER-stress 
and ER transmembrane proteins that take part in UPR process. Imbalances in the 
homeostasis process in ER such as oxidative stress, calcium homeostasis imbalance 
results ER-stress and prolonged ER-stress results in the failure of UPR which activates 
CHOP as a downstream effector of ER transmembrane proteins, i.e. PERK, ATF6 and IRE1 
(Figure 30). These proteins ubiquitously express CHOP, and when the unfolded protein 
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response triggered by the ER is not resolved, these transmembrane proteins activates 
CHOP and initiates apoptotic cells death through interacting with the different members 
of BCL-2 family proteins (Figure 30). One of the prominent BCL-2 family protein is BH-3 
only protein which further activate BAX and BAK apoptotic proteins that initiates 
apoptosis through caspase-12 activation. However, we suspect that U937 cells might not 
follow this pathway as the caspase-3 (which is an executioner caspase) gets oxidized and 
inactivated which is later followed by necrotic cell death as demonstrated previously 
(Baird et al., 2005). 
4.1.2.1 Problems associated with oxLDL induced CHOP activation  
Through our entire project, the main aim was to observe CHOP activation in U937 cells. 
We initiated the objective with TG as a positive treatment to obtain CHOP activation. Since 
CHOP related work was never done in this research group before, the first task was to 
perform western blot with the right amount of cell concentration, antibody blocking 
solution concentrations.  
We initiated work by using U937 cells at 0.5 × 106 cell/mL concentration. The cells were 
lysed, and protein was extracted (as described in 2.12.3). Protein concentration was 
determined using BCA assay (as described in 2.9.1) and 150 µg of protein was used to 
perform immunoblot. The SDS-PAGE gel was run, and the proteins were transferred to a 
nitrocellulose membrane using Transblot turbo mini transfer packs (Bio-Rad). The 
membrane was blocked with 5% for an hour, washed with 1X TBS containing 0.05% 
tween20 and was probed with CHOP antibody for an hour with 1: 1000 antibody dilution 
in 1% TBSM. The membranes were washed again with 1X TBS and probed with secondary 
antibody in 2% TBSM for 1 hour. The antibody was discarded, washed with TBS and 
visualized. Upon visualization no CHOP activation was seen. The procedure mentioned 
above was very successful for CD36 determination but was not optimized for determining 
CHOP activation.  
Another critical problem that we encountered was oxLDL induced CHOP activation. We 
found that only certain batch (s) of oxLDL induced CHOP in U937 cells. Out of 3 batches 
of oxLDL prepared, we observed CHOP activation in only one batch. Therefore, this had 
been a significant problem throughout the project suggesting that Cu-oxLDL is tricky on 
its own to fire up CHOP as previously mentioned the toxicity differs from batch to batch 
90 
 
so does the CHOP activation. However, we do not know as of why CHOP activation differs 
from batch to batch of oxLDL.  
  
  
4.1.2.2 Western blotting developmental method for CHOP activation. 
After failure with the method previously used for CD36 determination as a basis for CHOP 
determination, it was quite difficult to optimize the entire protocol. With several 
methodological reviews, we developed a draft with numerous changes. The main changes 
included antibody dilutions, durations and concentrations of blocking solutions, duration 
of antibody incubation and temperature at which the antibody is being incubated at. We 
decided not to change the cell concentration. So, the cell concentration was kept constant 
at 0.5 × 106 cells/mL. The cells were lysed as described in 2.12.3 and the protein 
concentration was determined as described in 2.9.1 and 100 µg protein was used, gel 
electrophoresed and was transferred onto a nitrocellulose membrane using a transblot 
turbo mini transfer packs (Bio-Rad). We did not change the procedure of blocking 
membrane with 5% TBSM. After blocking, the membrane was washed 5 times for 25 
minutes with 1X TBS containing 0.1% Tween. The next step was very crucial with 
antibody dilution and use of an appropriate amount of TBSM. So, this step was done 
incubating membrane in 2.5% TBSM in CHOP antibody with antibody diluted at 1: 750 
dilution. This was followed by incubating membrane overnight on a shaker at 40C 
(approximately 12-14 hours of incubation). The next day antibody was discarded 
followed by a quick 1X TBST wash and later 5X washing for 25 minutes before secondary 
antibody incubation. The secondary antibody incubation was again done in 2.5% TBSM 
at 1: 1000 dilution for 1 hour at RT; washed with 1X TBS, 5X for 25 minutes and 
visualized. Various exposure time was tried to observe CHOP activation and a barely 
visible band around 29 KDa could be spotted when the membrane was exposed for 5 
minutes 30 seconds and more. The possible reason for barely visible CHOP was due to 
lower antibody concentration. This assumption was confirmed when the CHOP antibody 
was used at highest dilution, i.e. at 1: 250 without changing any other step. At this 
concentration, the CHOP band was sharp and clear as seen in Figure 20. The entire 
C TG 0.1 0.2 0.3 0.4 0.5 C TG 0.2 0.4 0.6 0.8 1.0 
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protocol was optimized based on these observations and is described in detail in section 
2.12.5. 
4.1.2.3 Future work 
Future work can be done on CHOP activation using acLDL instead of Cu-oxLDL as there 
are plenty of evidences (see APPENDIX) suggesting the better signal in CHOP activation 
in various cell lines. This work can be further carried on U937 cells or THP-1 or human 
monocytes to study ER-stress. Alternately work can also be carried out by siRNA 
transfection to determine the different mechanisms in the cells. We also think that cell 
might undergo necroptosis through IRE1-dependent RIDD-MLKL pathway that can be 
studied further. 
4.1.3 The potential role of ACAT in diminishing 
atherosclerosis development. 
Until now we have been looking the relationship between scavenger receptors, oxLDL, 
oxidative stress and ER-stress. It is not only that oxLDL alone contributes to cellular death 
process but, there is another factor that is equally responsible for cell death and its 
survival. This vital factor is the maintenance of cholesterol homeostasis in the cell. The 
cholesterol imbalance in the cells is maintained by an enzyme known as acyl-coenzyme 
A: cholesterol acyltransferase (ACAT) (C. Chang et al., 2006; Leon, Hill, & Wasan, 2005). 
The main enzyme that is responsible for esterification of free cholesterol (FC) and long 
chain fatty acids to cholesterol esters (CE) with ATP and coenzyme A (CoA) required as 
cofactors (Goodman, Deykin, & Shiratori, 1964; Mukherjee, Kunitake, & Alfin-Slater, 
1958). ACAT is known to occur in 2 isoforms; ACAT-1 expressed only in macrophages and 
smooth muscles cells (SMCs) whereas liver and intestine express ACAT-1 and ACAT-2 
(Buhman et al., 2000). 
Based on its distribution ACAT play its part quite efficiently. Liver maintains regulation 
of plasma lipoprotein concentration; however, synthesis and processing cholesterol is 
maintained by both liver and brain. After triglyceride core of cholesterol is being 
lipolyzed by lipoprotein lipase, the remaining VLDL particles are either removed by the 
liver or are converted to LDL particles which are later taken up by the peripheral tissues 
via LDL receptor (Leon et al., 2005). Reverse cholesterol transport occurs when the 
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cholesterol is taken up by the peripheral tissues and is transferred back to the liver. In 
this situation, HDL is known to have a role in reverse cholesterol transport where 
cholesterol is secreted into bile and excreted in faeces. The presence of these two 
processes leads to cholesterol regulation in liver (Leon et al., 2005). 
In macrophages, the excess cholesterol present in the foam cells undergoes efflux on HDL 
by ATP binding cassette A1 and G1 (ABCA1 And G1) transporters and is then transported 
to the liver for further excretion. 7-KC being a major oxysterol in oxLDL is also known to 
impair ABCA1 transporter as a result, FC is prevented from moving out of the cell. This 
causes membrane vesicles which are filled with CE to accumulate in the cytoplasm. With 
the progression of the atherosclerotic lesion, ACAT, ABCA1 and ABCG1 transporter 
malfunction (Moore & Tabas, 2011) as a result the intracellular accumulation of excess 
FC causes macrophage death via endoplasmic reticulum-mediated cell apoptosis (Bo 
Feng et al., 2003; I Tabas, 2004). 
Many pieces of evidence suggests that ACAT inhibitors play a pivotal role in 
atherosclerosis and lipoprotein mechanism. However, different inhibitors have a 
different mode of action. ACAT inhibitor Pfizer CI-1011 decreased the lesional area and 
foam cell content from rich aorta by 35 and 27% suggesting its direct inhibitory within 
the vessel when studied on New Zealand white rabbits (Bocan et al., 2000). Another ACAT 
inhibitor Sandoz 58-035 has been widely used in the ACAT inhibition and atherosclerosis. 
Studies were done on the human macrophages in the presence of acLDL and foam cell 
formation with Sandoz 58-035 decreased cholesterol accumulation by lowering high-
affinity binding of 125I-acLDL and improving the efflux of cholesterol (Rodriguez, 
Bachorik, & Wee, 1999). The study also showed that the inhibitor at lower concentrations 
is not cytotoxic to the cells (Rodriguez et al., 1999). Based on the study on ACAT inhibitor 
Sandoz 58-035, we also obtained the similar results with U937 cells. The inhibitor at 
lower concentrations (10 µg/mL) protected the cells from further cell death when the 
cells were incubated with 0.1 and 0.2 mg/mL Cu-oxLDL for 24 hours. However, in that 
particular experiment the ACAT inhibitor alone control resulted in less than 50% viable 
cells which is not suppose to happen with the inhibitor, so we further planned to observe 
the cytotoxic effect of the inhibitor on cells and found that the cytotoxicity inhibitor is 
maximum as the concentration is increased with LC50 to be 60.12 ug/mL. This suggests 
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that ACAT inhibitor can be used at lower concentrations ranging from 1 µg/mL–10 
µg/mL.  
4.1.3.1 Possible Problems 
Possible problems that could further affect the work could be the changing toxicity of 
oxLDL. Sean (2016) during his studies reported that oxLDL toxicity is changed over few 
weeks after it is prepared. In the current research we observed that the toxicity changes 
with every new batch prepared, however, the toxicity remains between 0.1-0.5 mg/mL. 
In some rare cases, the Cu-oxLDL toxicity was also observed to be above 1mg/mL. Due to 
this variation in oxLDL toxicity over the period of times and batches prepared there are 
high chances that results may vary as well.  
4.1.3.2 Future Work 
The future implications of this novel ACAT inhibitor can be used to see its direct effect on 
human monocytes and macrophages to confirm its protective action. Alternatively, its 
potency can also be analysed by feeding the cells (U937, THP-1, human monocytes and 
macrophages) with FC complexed with methyl-β-cyclodextrin (M-β-CD), a compound 
known to form stable complexes with FC and is highly suitable FC and ACAT inhibition 
studies.  
4.1.4 Role of macrophage antioxidant 7,8–dihydroneopterin 
on CHOP expression. 
7,8-DNP is synthesized by γ-interferon activated macrophages and is known to be a 
potent antioxidant to prevent lipid oxidation and macrophage cell death (S. P. Gieseg et 
al., 2010; Müller et al., 1991). Based on the effectiveness and potency of 7,8-DNP in the 
prevention of lipid oxidation and macrophage cells death, we thought on looking its 
antioxidant aspect on CHOP activation. As NOX also play an essential role in CHOP 
activation and is also known as an important mediator of ROS we thought of looking its 
effect on CHOP. 7,8-DNP can downregulate TG induced CHOP expression in U937 cells as 
seen in Figure 19. Based on densitometry images and statistical data it was observed that 
7,8-DNP is effective in downregulating TG-induced CHOP expression in U937 cells. 
However, due to variability in oxLDL toxicity, oxLDL-induced CHOP expression by 
different batches, time limitations and delayed arrival of materials we could not achieve 
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our final goal to see the effect of 7, 8-DNP on Cu-oxLDL induced-CHOP expression. But, 
we suspect that 7, 8-DNP will downregulate oxLDL induced CHOP expression. Uptake of 
oxLDL is mainly regulated by CD36, and it has been previously shown that 7, 8-DNP 
downregulates CD36 in presence of sub-lethal dose of oxLDL (Nooshin, 2017). Therefore, 
if 7, 8-DNP is effective in downregulating CD36 in presence of oxLDL, there are 
possibilities that the antioxidant might downregulate oxLDL-induced CHOP expression 
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 FGF21 decreases foam 
cell formation with 
reduced lipid droplets, 
7KC induced apoptosis 
and TC levels. 
 Inhibitor blocked 
Phospho-ERK signalling 
and decreased ERK1/2 
levels. 
 FGF21 suppressed 7KC 
induced CHOP 
expression and DR5 






 (E. Li et 
al., 
2015) 






















 mRNA expression of 
TLR7 was detected in 
IVA infected, and IMQ 
treated group indicating 
the activation of TLR7 by 
IMQ treatment and IVA 
infection. 




 IMQ had no antiviral 
effect in vitro. DEX 
inhibited pro-
inflammatory cytokine 
secretion without a 
reduction in apoptosis. 
 oxLDL triggered 
apoptosis with TLR7 
activation. 
 IVA infection induced ER 
stress and that CHOP 
played a role in IVA-
induced apoptosis. 
 mRNA expression of 
GRP78 depicted a 10 fold 
increase and CHOP 






 MTT assay 













increase when cells were 
treated with 
tunicamycin. 
  acLDL 
 




 Caspase 3, 7 activities 
increased with 100 
ug/mL acLDL. 
 acLDL induced 
intracellular TC and CE 
(Total Cholesterol and 
Cholesteryl esters)  
 CHOP levels increased 
with increasing acLDL 
concentration in a time-
dependent manner. 
 acLDL induced FC 
triggered apoptosis by 
trafficking cholesterol to 
ER upregulating CHOP 
expression. 





 Caspase 3, 7 
assays 





CHOP and Bcl-2 
detection 


















 Calcium-induced CaMKII 
activation induces NOX 
and oxidative stress that 
are necessary for ER-
stress induced 
apoptosis. 
 ER-stress – CHOP – 
Calcium – CaMKII – JNK 
apoptotic pathway is 
bidirectional rather than 
linear. 
 NOX2 deficiency 
suppressed both CaMKII 
activation and CHOP 
induction under ER-
stress conditions. 
 Partial induction of 













 (G. Li et 
al., 
2010) 








esterification of ingested 
cholesterol by 90% but 
























 M-β-CD or CD 
(Methyl-Beta-
Cyclodextrin). 





did not affect the 
accumulation of 
cholesterol in the plasma 
membrane. 
 acLDL induced FC 
uptake by macrophages 
in the presence of ACAT 




 Androstenediol does not 
block cholesterol 
trafficking to ER in 
macrophages, did not 
block acLDL induced FC-
induced cell death even 
at higher concentrations 
(1 uM). 
 Accumulation of excess 
FC (using CD: Chol) in 
the plasma membrane is 
not sufficient to induce 
apoptosis in FC-loaded 
macrophages compared 




 Blocking cholesterol 
traffic to ER membranes 
with a low dose of 
U18666A blocked CHOP 
induction in acLDL 
induced FC-loaded 
macrophages. 
 CHOP induction by 
acLDL induced 
androstenediol did not 
block FC, and neither did 
U18666A blocked CHOP 
induction by A23187 
suggesting U18666A is 
not a direct inhibitor of 
CHOP nor general 















 Laser Capture 
microdetection 








XBP1, CHOP, ATF4, and 
PERK which are 
downstream effectors of 
UPR.   
  ACAT Inhibitor 
S58035 

















 acLDL induced FC 
loading in macrophages 
induced CHOP after 10h 
from WT mice. 
 P38 phosphorylation 
showed a biphasic 
pattern; moderate 
expression of 2-5 hr after 
acLDL induced FC 
loading, decreased 
expression between 5-
10 hr and increased 
expression by 15h. 
 CHOP expression was 
consistent after acLDL 
induced FC loading to 
15h. 
 Staurosporine did not 
activate CHOP. 
 FC loading by Chol: CD 
did not induce apoptosis. 
 FC loading induced by 
CD-Chol lead to the 
induction of CHOP and 
Phospho-PERK. 
































 oxLDL uptake by CD36 
induced ER-stress in the 
cells was observed when 
TM promoted uptake of 
ox-LDL in a 
concentration-
dependent manner (0.5 – 
2 mg/L), and PBA 
inhibited ox-LDL uptake 
by TM. 
 TM up-regulated the 
levels of CD36 protein 
and mRNA in 
 Lipid uptake 
assay using oil 
red O stain. 
 Immunofluores


















 Exposure of cells with 
TM and ox-LDL together 
or alone all induced ER-
stress as determined by 
phosphorylation of 
PERK and IRE-1 and 
upregulation of XBP-1, 
GRP78 and nuclear 
translocation of ATF6. 
 GRP78 levels were 
higher in macrophages 
treated with ox-LDL and 
TM together as 
compared to 
macrophages treated 
with ox-LDL alone.  
 siRNA directed against 
ATF6, IRE-1 and GRP78 
reduced oxLDL induced 
CD36 protein 
upregulation. 
 ER-stress inducer PBA 
reduced CD36 
upregulation in apoE 
deficient mice. 
  Cholesterol 
 Synthetic 
phospholipids 







 The research study also 
includes mouse 
peritoneal macrophages 
from C57BL6/J WT mice, 
HEK293 cells, and 
microsomes. 
 acLDL induced FC-
loaded macrophages, 
and mouse peritoneal 
macrophages express 
SERCA2b. Control mouse 
peritoneal macrophages 
express CHOP after 5h of 




were incubated with CD: 

























ATPase activity and 
SERCA2b mediated 
calcium uptake in a dose-


















 U0126 (ERK 
inhibitor)  
 NO LIPID 
LOADING 
 CHOP is critical for 
transcriptional up-
regulation of Bim.  
 Bim proteins and BIM 
mRNA increased 
significantly in WT 
thymocytes. 
 Peritoneal macrophages 
from chop-/- mice were 
reported to be 
abnormally resistant to 
apoptosis induced 
by the ER stressors 
indomethacin or 
Thapsigargin. 
 Chop-/- mice failed to 
upregulate Bim in 
response to treatment 
with Thapsigargin. 
 Thapsigargin 


























 Brefeldin A 
 NO LIPID 
LOADING. 
 
 UPR markers CHOP, 
GRP78 upregulated by 
UPR receptors IRE1, 
ATF6 and PERK by the 
addition of Tunicamycin 
 Mitochondria released 
cytochrome c when ER-























 ATF4 siRNA 
 CHOP siRNA 
 NO LIPID 
LOADING. 
 Cell viability decreased 
to 70%, 54% and 35% in 
NaF, Tu and Tg 
treatment groups 
respectively. 
 NaF and Tu resulted in 
autophagosome 
formation which was 














assessed by MDC (mono 
dansylcadaverine) 
 Tg alone induced 
apoptosis. 
 Tg treatment increased 
phospho-eIF2α, ATF4, 
CHOP, IRE1 and GRP 
levels 
 The addition of ATF4 
siRNA to Tu and NaF 
treated cells suppressed 
autophagy activated by 
ER-stress inducers. 
 The addition of CHOP 
siRNA to NaF and Tu 
treated cells did not 
suppress autophagy, but 
in turn, Tg-treated cells 
activated autophagy 
with increased ATF4 
expression suppressing 







 shRNA is 
targeting LOX-
1 transcript. 








 AEBSF (ATF6 
inhibitor) 
 oxLDL 
 oxLDL activated ER-
sensors IRE-1, PERK, 
GRP78 through LOX-1. 
 The inhibitors prevented 
oxLDL-induced EC 
apoptosis. 
 oxLDL activated 
proapoptotic mediators 
(CHOP, Bcl-2 and 
Caspase 12). 
 siRNA 
transfection 
 Western 
Blotting 
 PCR 
 (Hong 
et al., 
2014) 
 
 
